Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Breast Cancer

Free Subscription Articles published in Ann Surg Oncol Retrieve available abstracts of 485 articles: HTML format

Single Articles

October 2025
1. BIRGIN E, Rahbari NN
   Robotic Central Hepatectomy.
   Ann Surg Oncol. 2025;32:7252-7253.
   PubMed     Abstract available
   
   
   September 2025
2. DOUGLAS SR, van den Bruele AMB, Chiba A
   ASO Author Reflections: Lessons Learned from Neoadjuvant Endocrine Therapy use for Estrogen Receptor Positive Breast Cancer during the Covid-19 Pandemic.
   Ann Surg Oncol. 2025 Sep 23. doi: 10.1245/s10434-025-18380.
   PubMed    
   
   
   
3. MUNCK F, Tvedskov THF
   Reply to "Comment on TAD Outcomes from the Danish Breast Cancer Group Database".
   Ann Surg Oncol. 2025 Sep 23. doi: 10.1245/s10434-025-18419.
   PubMed    
   
   
   
4. DOUGLAS SR, Thomas SM, Chiba A, DiNome ML, et al
   Contemporary Trends in Axillary Surgery for ER-Positive, HER2-Negative Breast Cancer Stratified by Neoadjuvant Endocrine Therapy, Neoadjuvant Chemotherapy, or Upfront Surgery.
   Ann Surg Oncol. 2025 Sep 23. doi: 10.1245/s10434-025-18225.
   PubMed     Abstract available
   
   
   
5. DOUGLAS SR, Thomas SM, van den Bruele AB, Wang T, et al
   Neoadjuvant Endocrine Therapy Use in Estrogen Receptor Positive Breast Cancer: Insights from Practice Shifts During the COVID-19 Pandemic.
   Ann Surg Oncol. 2025 Sep 20. doi: 10.1245/s10434-025-18307.
   PubMed     Abstract available
   
   
   
6. WAGNER BD, Rubin J, Boe LA, Diwan R, et al
   Are We Underestimating Breast Cancer-Related Lymphedema? The Impact of Diagnostic Thresholds and Compression Therapy.
   Ann Surg Oncol. 2025 Sep 19. doi: 10.1245/s10434-025-18334.
   PubMed     Abstract available
   
   
   
7. MALHOTRA S, Choi DX, Sevilimedu V, Greenup RA, et al
   ASO Visual Abstract: Medicaid Expansion Is Associated With Lower Mortality in Patients With Locally Advanced Breast Cancer.
   Ann Surg Oncol. 2025 Sep 17. doi: 10.1245/s10434-025-18159.
   PubMed    
   
   
   
8. ARIMA J, Chida K, Wu R, Taniguchi K, et al
   ASO Author Reflections: Predictors of Immune Checkpoint Inhibitor Response in ER+/HER2- Breast Cancer: A New Role for ESR1?
   Ann Surg Oncol. 2025 Sep 17. doi: 10.1245/s10434-025-18377.
   PubMed    
   
   
   
9. ARIMA J, Chida K, Wu R, Taniguchi K, et al
   ESR1 Expression Negatively Correlates with Immune Cell Infiltration and Response to Immune Checkpoint Inhibitors in Estrogen Receptor-Positive/HER2-Negative Breast Cancer.
   Ann Surg Oncol. 2025 Sep 16. doi: 10.1245/s10434-025-18260.
   PubMed     Abstract available
   
   
   
10. MUNCK F, Jensen MB, Hawaz-Ali R, Tvedskov THF, et al
    ASO Visual Abstract: Oncologic First Events in Breast Cancer Patients After Targeted Axillary Dissection.
    Ann Surg Oncol. 2025 Sep 16. doi: 10.1245/s10434-025-18256.
    PubMed    
    
    
    
11. ZATECKY J, Coufal O
    De-escalation of Axillary Surgery in Inflammatory Breast Cancer: The Right Time is Coming.
    Ann Surg Oncol. 2025 Sep 15. doi: 10.1245/s10434-025-18356.
    PubMed    
    
    
    
12. HUANG SY, Murray M, Rubio A, Okoro N, et al
    Impact of Screening Mammography on Breast Cancer Outcomes in Women Aged 80 Years and Over.
    Ann Surg Oncol. 2025 Sep 13. doi: 10.1245/s10434-025-18288.
    PubMed     Abstract available
    
    
    
13. JENSEN S, Tvedskov T, Bechmann T, Tramm T, et al
    ASO Author Reflections: Is Axillary Lymph Node Dissection Always Justified for Residual Axillary Disease in Breast Cancer After Neoadjuvant Chemotherapy?
    Ann Surg Oncol. 2025 Sep 12. doi: 10.1245/s10434-025-18302.
    PubMed    
    
    
    
14. AN SJ, Spanheimer PM
    Reply to Letter to the Editor: "Reassessing Predictors of Nodal Pathologic Complete Response in Breast Cancer: Methodological Strengths and Data Gaps in the National Cancer Database Analysis," by Altundag.
    Ann Surg Oncol. 2025 Sep 10. doi: 10.1245/s10434-025-18234.
    PubMed    
    
    
    
15. TEKCAN SANLI DE, Sanli AN
    Comment on TAD Outcomes from the Danish Breast Cancer Group Database.
    Ann Surg Oncol. 2025 Sep 10. doi: 10.1245/s10434-025-18318.
    PubMed    
    
    
    
16. SHOJAEIAN F, Vasigh M, Del Calvo H, Chaves LG, et al
    Neoadjuvant Versus Adjuvant Therapy for Metaplastic Breast Cancer: Insights from the National Cancer Database-Is There a Winning Strategy?
    Ann Surg Oncol. 2025 Sep 10. doi: 10.1245/s10434-025-17937.
    PubMed     Abstract available
    
    
    
17. NELIS M, Chichura A, Al-Hilli Z
    ASO Author Reflections: Reevaluating Treatment Sequence in Metaplastic Breast Cancer.
    Ann Surg Oncol. 2025 Sep 9. doi: 10.1245/s10434-025-18316.
    PubMed    
    
    
    
18. TEKCAN SANLI DE, Sanli AN
    Preoperative Radiation Boost in Early-Stage Breast Cancer: Effect on Re-excision and Complication Rates.
    Ann Surg Oncol. 2025 Sep 6. doi: 10.1245/s10434-025-18322.
    PubMed    
    
    
    
19. KYEI I, Bea VJ, Gyan KK, Adjei E, et al
    Oncologic Anthropology and the African Diaspora: Twenty-Year Anniversary Report, International Center for the Study of Breast Cancer Subtypes (ICSBCS).
    Ann Surg Oncol. 2025 Sep 6. doi: 10.1245/s10434-025-17807.
    PubMed     Abstract available
    
    
    
20. LIN Y, Wang YY, Xu ZB, Dong L, et al
    ASO Visual Abstract: miRNAs Associated with Axillary Lymph Node Metastasis in Breast Cancer: A Systematic Review and Meta-Analysis.
    Ann Surg Oncol. 2025 Sep 5. doi: 10.1245/s10434-025-18205.
    PubMed    
    
    
    
21. MARIN C, Strawderman M, Peterson D, Cheng Z, et al
    ASO Visual Abstract: Biology is Queen-The Oncotype DX 21-Gene Recurrence Score has Stronger Prognostic Ability than Lymph Node Burden for Patients with Breast Cancer.
    Ann Surg Oncol. 2025 Sep 5. doi: 10.1245/s10434-025-18244.
    PubMed    
    
    
    
22. OROZCO JIJ, Valdez BJ, Trasatti ES, Brown SM, et al
    Do Patients with DCIS or Invasive Breast Cancer Carry the Same Risk for Genetic Mutation?
    Ann Surg Oncol. 2025 Sep 4. doi: 10.1245/s10434-025-18284.
    PubMed    
    
    
    
23. AN SJ, Thai CHNC, Agala CB, Abdou YG, et al
    ASO Visual Abstract: Predictors of Nodal Pathologic Complete Response After Neoadjuvant Chemotherapy in Breast Cancer.
    Ann Surg Oncol. 2025 Sep 4. doi: 10.1245/s10434-025-18238.
    PubMed    
    
    
    
24. FUJINO S, Yamashita K, Okamoto R, Shibaki S, et al
    ASO Visual Abstract: Exploring the Role of CDO1 in Breast Cancer: Insights into Tumor Biology and Therapeutic Potential.
    Ann Surg Oncol. 2025 Sep 4. doi: 10.1245/s10434-025-18105.
    PubMed    
    
    
    
25. DE JESUS EM, Elmore LC, Fayanju OM
    Annals of Surgical Oncology Landmark Series Disparities in Surgical Oncology: Breast Cancer.
    Ann Surg Oncol. 2025 Sep 3. doi: 10.1245/s10434-025-18157.
    PubMed     Abstract available
    
    
    
26. THOMPSON D, Fefferman M, Simovic S, Kuchta K, et al
    ASO Visual Abstract: Impact of Quality Improvement Interventions on Biopsy to Treatment Time in Breast Cancer-Results from the PROMPT Quality Collaborative of the National Accreditation Program for Breast Centers.
    Ann Surg Oncol. 2025 Sep 3. doi: 10.1245/s10434-025-18179.
    PubMed    
    
    
    
27. CHAKRABORTY MA, Haffty BG
    ASO Author Reflections: Preoperative Radiation Boost Reduces Re-Excision Rate and Locoregional Treatment Time in Early-Stage Breast Cancer Patients.
    Ann Surg Oncol. 2025 Sep 2. doi: 10.1245/s10434-025-18271.
    PubMed    
    
    
    
28. YUEN S, McCool K, Bharucha M, Narloch K, et al
    ASO Visual Abstract: Evaluating Trends in Fertility Counseling Among Reproductive-Age Patients with Breast Cancer.
    Ann Surg Oncol. 2025 Sep 2. doi: 10.1245/s10434-025-18129.
    PubMed    
    
    
    
29. LEVY J, Wagner BD, Roberts A, Shammas RL, et al
    The Impact of Travel Distance on Patient Outcomes after Breast Reconstruction.
    Ann Surg Oncol. 2025;32:6629-6639.
    PubMed     Abstract available
    
    
    
30. OU X, Liu Z, Liu C, Wang K, et al
    Surgical and Oncologic Outcomes of Tumescence and Sharp Dissection Versus Electrocautery Dissection in Minimal-Access Nipple-Sparing Mastectomy with Immediate Prosthesis Breast Reconstruction: A Real-World Retrospective Cohort Study.
    Ann Surg Oncol. 2025;32:6660-6670.
    PubMed     Abstract available
    
    
    
31. CHAKRABORTY MA, Sherwani ZK, Narra LR, Abou Yehia Z, et al
    ASO Visual Abstract: Preoperative Radiation Boosts Results in Low Rates of Re-Excision and Reduced Locoregional Treatment Time for Breast Cancer Patients.
    Ann Surg Oncol. 2025 Sep 1. doi: 10.1245/s10434-025-18245.
    PubMed    
    
    
    August 2025
32. VAN HASSEL J, Dimitroff K, Yau C, Mukhtar R, et al
    ASO Visual Abstract: Impact of Time to Surgery Post Neoadjuvant Chemotherapy on Breast Cancer Outcomes: A Retrospective Study of Patients Enrolled in the I-SPY 2 Clinical Trial.
    Ann Surg Oncol. 2025 Aug 29. doi: 10.1245/s10434-025-18131.
    PubMed    
    
    
    
33. CHU C, Goldman J, Joung H, Go S, et al
    Breast Cancer Incidence Among Patients Undergoing Chest Masculinization Surgery: A Scoping Review.
    Ann Surg Oncol. 2025 Aug 28. doi: 10.1245/s10434-025-18156.
    PubMed     Abstract available
    
    
    
34. VARMAN PM, Conner A, Bennett WC, Taft D, et al
    ASO Visual Abstract: Impact of Second Opinions on Time to Treatment of Breast Cancer.
    Ann Surg Oncol. 2025 Aug 27. doi: 10.1245/s10434-025-18180.
    PubMed    
    
    
    
35. YI M, Chavez-MacGregor M, Smith BD, Mitchell MP, et al
    ASO Visual Abstract: Comparing Survival Differences Between Patients Undergoing Breast-Conserving Therapy Versus Total Mastectomy as a First Treatment for Early Stage Breast Cancer.
    Ann Surg Oncol. 2025 Aug 27. doi: 10.1245/s10434-025-18217.
    PubMed    
    
    
    
36. REASON EH, Thomas SM, Chanenchuk T, Botty van den Bruele A, et al
    ASO Visual Abstract: Neoadjuvant Chemotherapy is Not Associated with Improved Overall Survival in Metaplastic Breast Cancer Regardless of Tumor Subtype.
    Ann Surg Oncol. 2025 Aug 26. doi: 10.1245/s10434-025-18181.
    PubMed    
    
    
    
37. AMBURN T, Downs-Canner S
    ASO Author Reflections: Nipple-Sparing Mastectomy for Breast Cancer Patients with Nipple Discharge.
    Ann Surg Oncol. 2025 Aug 23. doi: 10.1245/s10434-025-18078.
    PubMed    
    
    
    
38. LYONS W, Fish EM, Bleicher RJ, Chang C, et al
    Management and Outcomes in Patients with Breast Cancer with 1-of-1 and 2-of-2 Positive Sentinel Nodes.
    Ann Surg Oncol. 2025 Aug 23. doi: 10.1245/s10434-025-18097.
    PubMed     Abstract available
    
    
    
39. NAASEH A, Tang SX, Maytin-Hevia AR, Wu N, et al
    ASO Visual Abstract: Are Broadened Guidelines Improving Our Detection of Pathologic Genetic Mutations in Breast Cancer Patients? A 5-Year Comparative Analysis of American Society of Breast Surgeons and National Comprehensive Cancer Network Guidelines.
    Ann Surg Oncol. 2025 Aug 23. doi: 10.1245/s10434-025-18182.
    PubMed    
    
    
    
40. SERRES SK, Saxon-Filipe S, Schwartz T
    Complementary and Alternative Medicine in Breast Cancer: Considerations for the Breast Surgical Oncologist.
    Ann Surg Oncol. 2025 Aug 23. doi: 10.1245/s10434-025-17850.
    PubMed     Abstract available
    
    
    
41. VAN HASSEL J, Dimitroff K, Yau C, Mukhtar R, et al
    Impact of Time to Surgery Post Neoadjuvant Chemotherapy on Breast Cancer Outcomes: A Retrospective Study of Patients Enrolled in the I-SPY 2 Clinical Trial.
    Ann Surg Oncol. 2025 Aug 23. doi: 10.1245/s10434-025-17933.
    PubMed     Abstract available
    
    
    
42. MUKHTAR RA, Dimitroff K, Yau C, Chien AJ, et al
    ASO Visual Abstract: Impact of Neoadjuvant Chemotherapy on Surgical Outcomes and Conversion to Node-Negativity in Invasive Lobular Breast Cancer: Analysis of Molecularly High-Risk Tumors by Histologic Subtype on the I-SPY2 Clinical Trial.
    Ann Surg Oncol. 2025 Aug 23. doi: 10.1245/s10434-025-18104.
    PubMed    
    
    
    
43. VETTER CD, C Boughey J
    ASO Author Reflections: Refining Prognostic Staging in De Novo Metastatic Breast Cancer: Validation, Limitations, and Future Directions.
    Ann Surg Oncol. 2025 Aug 23. doi: 10.1245/s10434-025-18113.
    PubMed    
    
    
    
44. MOHAN SC, Chen JH, Tidwell RSS, Kai M, et al
    ASO Visual Abstract: Investigating the Prognostic Impact of Postpartum Diagnosis in Women with De Novo Stage IV Inflammatory Breast Cancer.
    Ann Surg Oncol. 2025 Aug 21. doi: 10.1245/s10434-025-18098.
    PubMed    
    
    
    
45. CHAKRABORTY MA, Sherwani ZK, Narra LR, Abou Yehia Z, et al
    Preoperative Radiation Boost Results in Low Rates of Re-excision and Reduced Locoregional Treatment Time in Breast Cancer Patients.
    Ann Surg Oncol. 2025 Aug 20:10.1245/s10434-025-18089.
    PubMed     Abstract available
    
    
    
46. TASHJIAN NL, Hoskin TL, Leon-Ferre RA, Boughey JC, et al
    ASO Author Reflections: Survival of Patients with HER2-Positive Breast Cancer After Neoadjuvant Chemotherapy Based on Presenting Clinical Stage and Response to Neoadjuvant Chemotherapy.
    Ann Surg Oncol. 2025 Aug 20. doi: 10.1245/s10434-025-18188.
    PubMed    
    
    
    
47. MARIN C, Strawderman M, Peterson D, Cheng Z, et al
    Biology is Queen: The Oncotype DX 21-Gene Recurrence Score Has Stronger Prognostic Ability than Lymph Node Burden for Patients with Breast Cancer.
    Ann Surg Oncol. 2025 Aug 20. doi: 10.1245/s10434-025-18086.
    PubMed     Abstract available
    
    
    
48. MUNCK F, Jensen MB, Hawaz-Ali R, Tvedskov THF, et al
    Oncologic First Events in Breast Cancer Patients After Targeted Axillary Dissection.
    Ann Surg Oncol. 2025 Aug 20. doi: 10.1245/s10434-025-18068.
    PubMed     Abstract available
    
    
    
49. CHICHURA AM, Chen X, Nelis M, Kopicky L, et al
    Neoadjuvant Chemotherapy is Associated with Worse 5-Year Overall Survival in Patients with Metaplastic Breast Cancer Compared with Primary Surgery: A National Cancer Database Analysis.
    Ann Surg Oncol. 2025 Aug 20. doi: 10.1245/s10434-025-18085.
    PubMed     Abstract available
    
    
    
50. MALHOTRA S, Choi DX, Sevilimedu V, Greenup RA, et al
    ASO Author Reflections: Medicaid's Impact on Breast Cancer.
    Ann Surg Oncol. 2025 Aug 19. doi: 10.1245/s10434-025-18107.
    PubMed    
    
    
    
51. GHASEMI F, Young J, Asaoka M, Takabe K, et al
    ASO Author Reflections: Refining Breast Cancer Staging to More Accurately Reflect Disease Biology.
    Ann Surg Oncol. 2025 Aug 19. doi: 10.1245/s10434-025-18167.
    PubMed    
    
    
    
52. TASHJIAN NL, Hoskin TL, Leon-Ferre RA, Boughey JC, et al
    The Association of Clinical Stage at Presentation with Overall Survival of Patients who have HER2-Positive Breast Cancer Treated with Neoadjuvant Chemotherapy.
    Ann Surg Oncol. 2025 Aug 14. doi: 10.1245/s10434-025-18050.
    PubMed     Abstract available
    
    
    
53. LEE EG, Lee DE, Jung SY, Han JH, et al
    ASO Author Reflections: Multimodal Sentinel Lymph Node Mapping in Breast Cancer: Efficacy and Clinical Implications After Neoadjuvant Chemotherapy.
    Ann Surg Oncol. 2025 Aug 12. doi: 10.1245/s10434-025-18053.
    PubMed    
    
    
    
54. YI M, Chavez-MacGregor M, Smith BD, Mitchell MP, et al
    Comparing Survival Differences between Patients Undergoing Breast-Conserving Therapy Versus Total Mastectomy as a First Treatment for Early Stage Breast Cancer.
    Ann Surg Oncol. 2025 Aug 11:10.1245/s10434-025-18030.
    PubMed     Abstract available
    
    
    
55. THOMPSON D, Fefferman M, Simovic S, Kuchta K, et al
    Impact of Quality Improvement Interventions on Biopsy-to-Treatment Time in Breast Cancer: Results from the PROMPT Quality Collaborative of the National Accreditation Program for Breast Centers.
    Ann Surg Oncol. 2025 Aug 9. doi: 10.1245/s10434-025-17935.
    PubMed     Abstract available
    
    
    
56. KERIVAN L, Wagner J, Nye L, Balanoff C, et al
    ASO Visual Abstract: Surgical Choice Among Women with a First Breast Cancer and Pathogenic Variants in Breast Cancer Genes.
    Ann Surg Oncol. 2025 Aug 9. doi: 10.1245/s10434-025-18071.
    PubMed    
    
    
    
57. LIN Y, Wang YY, Xu ZB, Dong L, et al
    miRNAs Associated with Axillary Lymph Node Metastasis in Breast Cancer: A Systematic Review and Meta-Analysis.
    Ann Surg Oncol. 2025 Aug 9. doi: 10.1245/s10434-025-17983.
    PubMed     Abstract available
    
    
    
58. STARI OL, Torok C, Gorog PO, Markus B, et al
    ASO Author Reflections: The Completion May Lead to Conservation: Partial and Complete Intraoperative Ultrasound Enhanced Breast-Conserving Surgery for Invasive Breast Cancer.
    Ann Surg Oncol. 2025 Aug 8. doi: 10.1245/s10434-025-18009.
    PubMed    
    
    
    
59. LIN Y, Wang YY, Xu ZB, Dong L, et al
    ASO Author Reflections: MicroRNAs as Predictive Biomarkers for Axillary Lymph Node Metastasis in Breast Cancer.
    Ann Surg Oncol. 2025 Aug 8. doi: 10.1245/s10434-025-18075.
    PubMed    
    
    
    
60. KERIVAN LT, Larson KE
    ASO Author Reflections: Unilateral Cancer, Bilateral Decisions: Contralateral Risk-Reducing Mastectomy Performance in Patients with a First Breast Cancer and Positive Genetic Testing.
    Ann Surg Oncol. 2025 Aug 8. doi: 10.1245/s10434-025-18016.
    PubMed    
    
    
    
61. NAASEH A, Margenthaler JA
    ASO Author Reflections: Moving Beyond Risk-Based Genetic Testing Criteria: Supporting Universal Genetic Testing in Breast Cancer Patients.
    Ann Surg Oncol. 2025 Aug 8. doi: 10.1245/s10434-025-18074.
    PubMed    
    
    
    
62. CHEN SL, Shah C, Boyages J, Koelmeyer L, et al
    ASO Visual Abstract: The Importance of a Pretreatment Baseline When Screening Patients for Breast-Cancer-Related Lymphedema.
    Ann Surg Oncol. 2025 Aug 8. doi: 10.1245/s10434-025-18062.
    PubMed    
    
    
    
63. BLEICHER RJ
    ASO Author Reflections: The Worried Waiting-Breast Cancer Upstaging and In Vivo Growth During Preoperative Delays.
    Ann Surg Oncol. 2025 Aug 8. doi: 10.1245/s10434-025-18008.
    PubMed    
    
    
    
64. EDWARDS M, Elder K, Rose A, Tan E, et al
    ASO Visual Abstract: Survival Benefits and Less Intensive Treatment for Women Diagnosed with Early-Stage Breast Cancer While Participating in Population-Based Screening.
    Ann Surg Oncol. 2025 Aug 7. doi: 10.1245/s10434-025-18069.
    PubMed    
    
    
    
65. MANN GB
    ASBrS Keynote Address: Reimagining Stage 1 Breast Cancer-Evolution of Breast Cancer Management over the Last 120 Years.
    Ann Surg Oncol. 2025 Aug 7. doi: 10.1245/s10434-025-17849.
    PubMed    
    
    
    
66. CHEN JH, Warneke CL, Middleton L, Singh P, et al
    ASO Visual Abstract: Complication Rates Are Low After Invasive Procedures on the Lactating Breast in Patients Treated for Breast Cancer During Pregnancy.
    Ann Surg Oncol. 2025 Aug 7. doi: 10.1245/s10434-025-18064.
    PubMed    
    
    
    
67. BRENNAN MA, Plichta JK, Rozenblit M, Flanagan MR, et al
    Surgeon Attitudes on the Management of de novo Oligometastatic Breast Cancer.
    Ann Surg Oncol. 2025 Aug 6. doi: 10.1245/s10434-025-17912.
    PubMed    
    
    
    
68. FUJINO S, Yamashita K, Okamoto R, Shibaki S, et al
    Exploring the Role of CDO1 in Breast Cancer: Insights into Tumor Biology and Therapeutic Potential.
    Ann Surg Oncol. 2025 Aug 5. doi: 10.1245/s10434-025-17944.
    PubMed     Abstract available
    
    
    
69. LUBARSKY M, Hernandez AE, Borowsky PA, Thompson C, et al
    A Comprehensive Analysis of Unmet Social Needs in Breast Cancer Patients Treated at an Academic Cancer Center and Sister Safety-Net Hospital.
    Ann Surg Oncol. 2025 Aug 4. doi: 10.1245/s10434-025-17609.
    PubMed     Abstract available
    
    
    
70. ALTUNDAG K
    Reassessing Predictors of Nodal Pathologic Complete Response in Breast Cancer: Methodological Strengths and Data Gaps in the National Cancer Database.
    Ann Surg Oncol. 2025 Aug 4. doi: 10.1245/s10434-025-18055.
    PubMed    
    
    
    
71. CHEN JC, Handley D, Elsaid MI, Carson WE, et al
    Omitting Sentinel Lymph Node Biopsy in Small Hormone Receptor-Positive Breast Cancer: Does Race Matter?
    Ann Surg Oncol. 2025 Aug 4. doi: 10.1245/s10434-025-18038.
    PubMed    
    
    
    
72. LEE EG, Lee DE, Jung SY, Han JH, et al
    ASO Visual Abstract: Clinical Application of Multimodal Sentinel Lymph Node Mapping Method in Patients with Breast Cancer Undergoing Neoadjuvant Chemotherapy: A Final Analysis.
    Ann Surg Oncol. 2025 Aug 4. doi: 10.1245/s10434-025-17961.
    PubMed    
    
    
    
73. LUBARSKY M, Hernandez AE, Borowsky PA, Thompson C, et al
    ASO Visual Abstract: A Comprehensive Analysis of Unmet Social Needs in Patients with Breast Cancer Treated at an Academic Cancer Center and Sister Safety-Net Hospital.
    Ann Surg Oncol. 2025 Aug 3. doi: 10.1245/s10434-025-17720.
    PubMed    
    
    
    
74. VARMAN PM, Conner A, Bennett WC, Taft D, et al
    Impact of Second Opinions on Time to Treatment of Breast Cancer.
    Ann Surg Oncol. 2025 Aug 2. doi: 10.1245/s10434-025-17934.
    PubMed     Abstract available
    
    
    
75. SHAHEEN MS, Necker FN, Momeni A
    National Trends and Impact of Preoperative CT-Angiography on Autologous Breast Reconstruction.
    Ann Surg Oncol. 2025;32:5838-5844.
    PubMed     Abstract available
    
    
    
76. SCHUMACHER JR, Hanlon BM, Zahrieh D, Rathouz PJ, et al
    Impact of a Web-Based Decision Aid on Socioeconomically Disadvantaged Patients' Engagement in Breast Surgery Decision-Making: Stepped-Wedge Clinical Trial (Alliance-A231701CD).
    Ann Surg Oncol. 2025;32:5540-5550.
    PubMed     Abstract available
    
    
    
77. GOOCH JC, McClelland QY, Paschalis K, Dobbins J, et al
    Same Day Discharges Among Elderly Mastectomy Patients: A Single Institution Prospective Study.
    Ann Surg Oncol. 2025;32:5521-5527.
    PubMed     Abstract available
    
    
    
78. MUELLER C, Rangan R, Kruse M, Al-Hilli Z, et al
    Trends in the Management of Small HER2-Positive Breast Cancers.
    Ann Surg Oncol. 2025;32:5510-5520.
    PubMed     Abstract available
    
    
    
79. CAVALCANTE FP, de Oliveira VM, Ziegelmann PK, Brenelli FP, et al
    National Survey on Attitudes of Brazilian Breast Surgeons Regarding Oncoplastic Surgery: Success of a Training Model.
    Ann Surg Oncol. 2025;32:5489-5499.
    PubMed     Abstract available
    
    
    
80. HUYNH VD, Mouabbi J, Kuerer HM, Wanis KN, et al
    Characterization of the Germline Pathogenic Mutational Landscape and Oncologic Outcomes Among 877 Patients with Invasive Lobular Carcinoma.
    Ann Surg Oncol. 2025;32:5477-5488.
    PubMed     Abstract available
    
    
    
81. NAPIERALA MJ, Olszewski W, Rosinska M, Okarska-Napierala M, et al
    Residual Breast Tissue After Four Types of Mastectomy: A Prospective, Comparative Study.
    Ann Surg Oncol. 2025;32:5467-5476.
    PubMed     Abstract available
    
    
    
82. SOROUDI D, Parmeshwar N, Gozali A, Piper M, et al
    Post-Mastectomy Flat Closure: A Mixed-Methods Analysis of Patient Outcomes and Perspectives.
    Ann Surg Oncol. 2025;32:5827-5837.
    PubMed     Abstract available
    
    
    
83. HASSAN AM, Hajj JP, Lewis JP, Ahmed S, et al
    Long-Term Outcomes of Lymphedema After Immediate Lymphatic Reconstruction Following Axillary Lymph Node Dissection.
    Ann Surg Oncol. 2025;32:5817-5826.
    PubMed     Abstract available
    
    
    July 2025
84. MARTIN G, Kensler KH, Tamimi RM, Bea VJ, et al
    ASO Author Reflections: Reconstructing Equity: Policy's Role in Post-Mastectomy Breast Cancer Care.
    Ann Surg Oncol. 2025 Jul 31. doi: 10.1245/s10434-025-17941.
    PubMed    
    
    
    
85. YAO J
    ASO Author Reflections: Prospective Validation of Lymphatic Contrast-Enhanced Ultrasound for Non-invasive Sentinel Lymph Node Assessment in Breast Cancer.
    Ann Surg Oncol. 2025 Jul 31. doi: 10.1245/s10434-025-17761.
    PubMed    
    
    
    
86. MALHOTRA S, Choi DX, Sevilimedu V, Greenup RA, et al
    Medicaid Expansion Is Associated with Lower Mortality in Patients with Locally Advanced Breast Cancer.
    Ann Surg Oncol. 2025 Jul 30. doi: 10.1245/s10434-025-17865.
    PubMed     Abstract available
    
    
    
87. PRATT CG, McClelland PH, Long SA, Moore AN, et al
    The Metaplastic Conundrum: A National Cancer Database Analysis of Metaplastic versus Triple-Negative Ductal Breast Cancer.
    Ann Surg Oncol. 2025 Jul 29. doi: 10.1245/s10434-025-17932.
    PubMed     Abstract available
    
    
    
88. VETTER CD, Hoskin T, Olson C, Giridhar K, et al
    Validation of the Performance of the Novel Prognostic Staging System for Overall Survival in De Novo Metastatic Breast Cancer and Demonstration of Performance for Cancer-Specific Outcomes.
    Ann Surg Oncol. 2025 Jul 29. doi: 10.1245/s10434-025-17863.
    PubMed     Abstract available
    
    
    
89. REASON EH, Thomas SM, Chanenchuk T, Botty van den Bruele AM, et al
    Neoadjuvant Chemotherapy is Not Associated with Improved Overall Survival in Metaplastic Breast Cancer Regardless of Tumor Subtype.
    Ann Surg Oncol. 2025 Jul 29. doi: 10.1245/s10434-025-17938.
    PubMed     Abstract available
    
    
    
90. CHAN K, Yao K
    ASO Author Reflections: Leveraging Cancer Accreditation Standards to Improve the Delivery of Breast Cancer Care.
    Ann Surg Oncol. 2025 Jul 28. doi: 10.1245/s10434-025-17956.
    PubMed    
    
    
    
91. KERIVAN L, Wagner J, Nye L, Balanoff C, et al
    Surgical Choice among Women with a First Breast Cancer and Pathogenic Variants in Breast Cancer Genes.
    Ann Surg Oncol. 2025 Jul 27. doi: 10.1245/s10434-025-17859.
    PubMed     Abstract available
    
    
    
92. EDWARDS M, Elder K, Rose A, Tan E, et al
    Survival Benefits and Less Intensive Treatment for Women with Early-Stage Breast Cancer Diagnosed While Participating in Population-Based Screening.
    Ann Surg Oncol. 2025 Jul 25. doi: 10.1245/s10434-025-17845.
    PubMed     Abstract available
    
    
    
93. MOHAN SC, Johnson HM
    ASO Author Reflections: Postpartum Diagnosis of Stage IV Inflammatory Breast Cancer.
    Ann Surg Oncol. 2025 Jul 25. doi: 10.1245/s10434-025-17958.
    PubMed    
    
    
    
94. STARI OL, Torok C, Gorog PO, Kovacs B, et al
    May the Completion Lead to Conservation: Impact of Partial and Complete Intraoperative Ultrasound Application on Resection Margin Management During Breast-Conserving Surgery for Invasive Breast Cancer: A Retrospective Cohort Study.
    Ann Surg Oncol. 2025 Jul 24. doi: 10.1245/s10434-025-17822.
    PubMed     Abstract available
    
    
    
95. YUEN S, McCool K, Bharucha M, Narloch K, et al
    Evaluating Trends in Fertility Counseling among Reproductive-Age Patients with Breast Cancer.
    Ann Surg Oncol. 2025 Jul 24. doi: 10.1245/s10434-025-17857.
    PubMed     Abstract available
    
    
    
96. MUKHTAR RA, Dimitroff K, Yau C, Chien AJ, et al
    Impact of Neoadjuvant Chemotherapy on Surgical Outcomes and Conversion to Node-Negativity in Invasive Lobular Breast Cancer: Analysis of Molecularly High-Risk Tumors by Histologic Subtype on the I-SPY2 Clinical Trial.
    Ann Surg Oncol. 2025 Jul 24. doi: 10.1245/s10434-025-17862.
    PubMed     Abstract available
    
    
    
97. MOHAN SC, Chen JH, Tidwell RSS, Kai M, et al
    Investigating the Prognostic Impact of Postpartum Diagnosis in Women with De Novo Stage IV Inflammatory Breast Cancer.
    Ann Surg Oncol. 2025 Jul 24. doi: 10.1245/s10434-025-17855.
    PubMed     Abstract available
    
    
    
98. BLEICHER RJ, Ruth KJ, Williams AD, Ross EA, et al
    Breast Cancer Upstaging Risk and In Vivo Tumor Growth Rates Associated with Preoperative Delays.
    Ann Surg Oncol. 2025 Jul 23. doi: 10.1245/s10434-025-17867.
    PubMed     Abstract available
    
    
    
99. CHEN SL, Shah C, Boyages J, Koelmeyer L, et al
    The Importance of a Pre-treatment Baseline When Screening Patients for Breast-Cancer-Related Lymphedema.
    Ann Surg Oncol. 2025 Jul 23. doi: 10.1245/s10434-025-17854.
    PubMed     Abstract available
    
    
    
100. NAASEH A, Tang SX, Maytin-Hevia AR, Wu N, et al
     Are Broadened Guidelines Improving our Detection of Pathologic Genetic Mutations in Breast Cancer Patients? A 5-Year Comparative Analysis of American Society of Breast Surgeons and National Comprehensive Cancer Network Guidelines.
     Ann Surg Oncol. 2025 Jul 22. doi: 10.1245/s10434-025-17939.
     PubMed     Abstract available
     
     
     
101. OSHI M, Ghasemi F, Yamada A, Zhang J, et al
     ASO Author Reflections: Reframing Hippo Pathway Activation as a Prognostic and Predictive Biomarker in HER2-Positive Breast Cancer.
     Ann Surg Oncol. 2025 Jul 22. doi: 10.1245/s10434-025-17875.
     PubMed    
     
     
     
102. JONES M, Alsafwani ZW, Orozco JIJ, Lele SM, et al
     Pre-Treatment Tumor Collagen is Associated with Triple-Negative Breast Cancer Pathological Response to Chemo-Immunotherapy.
     Ann Surg Oncol. 2025 Jul 21. doi: 10.1245/s10434-025-17904.
     PubMed    
     
     
     
103. AN SJ, Thai CHNC, Agala CB, Abdou YG, et al
     Predictors of Nodal Pathologic Complete Response After Neoadjuvant Chemotherapy in Breast Cancer.
     Ann Surg Oncol. 2025 Jul 19. doi: 10.1245/s10434-025-17906.
     PubMed     Abstract available
     
     
     
104. CHEN JH, Warneke CL, Middleton L, Singh P, et al
     Complication Rates are Low After Invasive Procedures on the Lactating Breast in Patients Treated for Breast Cancer During Pregnancy.
     Ann Surg Oncol. 2025 Jul 17. doi: 10.1245/s10434-025-17856.
     PubMed     Abstract available
     
     
     
105. TAPIAVALA S, Liu Y, Roy S, Hensing W, et al
     Impact of National Society Guidelines and National Comprehensive Cancer Network (NCCN) Guidelines on Genetic Testing Use Among Patients with Breast Cancer.
     Ann Surg Oncol. 2025 Jul 14. doi: 10.1245/s10434-025-17448.
     PubMed     Abstract available
     
     
     
106. JOHNSON HM, Mitchell KB
     ASO Author Reflections: Oncolactation Guidelines for Patients with Breast Cancer.
     Ann Surg Oncol. 2025 Jul 14. doi: 10.1245/s10434-025-17793.
     PubMed    
     
     
     
107. VICINI FA
     Intraoperative Radiation Therapy for Early-Stage Breast Cancer: Promise or Peril?
     Ann Surg Oncol. 2025 Jul 14. doi: 10.1245/s10434-025-17785.
     PubMed    
     
     
     
108. JOHNSON HM, Miller ME, Mitchell KB
     Oncolactation for Patients with Breast Cancer: Executive Summary from the American Society of Breast Surgeons.
     Ann Surg Oncol. 2025 Jul 8. doi: 10.1245/s10434-025-17742.
     PubMed     Abstract available
     
     
     
109. KNOEDLER S, Jiang J, Moog P, Wirtz JM, et al
     ASO Visual Abstract: Predicting Outcomes of Breast-Conserving Surgery in Breast Cancer Patients Using the Modified 5-Item Frailty Index-A Retrospective Cohort Study.
     Ann Surg Oncol. 2025 Jul 5. doi: 10.1245/s10434-025-17625.
     PubMed    
     
     
     
110. KEEGAN G, Ravenell J, Crown A, DiMaggio C, et al
     Impact of Unmet Social Needs on Access to Breast Cancer Screening and Treatment: An Analysis of Barriers Faced by Patients in a Breast Cancer Navigation Program.
     Ann Surg Oncol. 2025 Jul 2. doi: 10.1245/s10434-025-17608.
     PubMed     Abstract available
     
     
     
111. CHIARELLA LS, Huelsboemer L, Diatta F, Klimitz FJ, et al
     The Five-Item Modified Frailty Index Predicts Adverse Surgical Outcomes in Patients Undergoing Mastectomy.
     Ann Surg Oncol. 2025;32:4829-4837.
     PubMed     Abstract available
     
     
     
112. SWITALLA KM, Falade IO, Quirarte A, Baxter M, et al
     Positive Margin Rates After Breast-Conserving Surgery by Histologic Subtype: A Systematic Review and Meta-analysis Evaluating the Impact of Oncoplastic Surgery.
     Ann Surg Oncol. 2025;32:4899-4909.
     PubMed     Abstract available
     
     
     
113. TAYLOR CD, Wang T, Sinco BR, Pilewskie M, et al
     National Variation in Implementation of Sentinel Lymph Node Biopsy for Clinically Node-Positive Patients Undergoing Neoadjuvant Therapy.
     Ann Surg Oncol. 2025;32:4874-4882.
     PubMed     Abstract available
     
     
     
114. KEEGAN G, Ravenell J, Crown A, DiMaggio C, et al
     ASO Visual Abstract: Impact of Unmet Social Needs on Access to Breast Cancer Screening and Treatment: An Analysis of Barriers Faced by Patients in a Breast Cancer Navigation Program.
     Ann Surg Oncol. 2025 Jul 1. doi: 10.1245/s10434-025-17716.
     PubMed    
     
     
     June 2025
115. LEE EG, Lee DE, Jung SY, Han JH, et al
     Clinical Application of Multimodal Sentinel Lymph Node-Mapping Method for Patients with Breast Cancer Undergoing Neoadjuvant Chemotherapy: A Final Analysis.
     Ann Surg Oncol. 2025 Jun 30. doi: 10.1245/s10434-025-17740.
     PubMed     Abstract available
     
     
     
116. HOSANG KM, Bleicher RJ, Yao KA, Dietz JR, et al
     ASO Visual Abstract: Low Socioeconomic Status at the Patient and Institutional Level Impact Achievement of Breast Cancer Quality Standards.
     Ann Surg Oncol. 2025 Jun 29. doi: 10.1245/s10434-025-17690.
     PubMed    
     
     
     
117. SILVERSTEIN MJ, Kim B, Lin K, Lloyd S, et al
     ASO Visual Abstract: Intraoperative Radiation Therapy (IORT) for Breast Cancer: The Final Analysis of a Prospective Cohort of 1828 Cases.
     Ann Surg Oncol. 2025 Jun 24. doi: 10.1245/s10434-025-17698.
     PubMed    
     
     
     
118. NGUYEN CL, Poels D, Teoh B, Rastogi P, et al
     Indocyanine Green Fluorescence-Guided Axillary Reverse Mapping for Axillary Lymph Node Dissection in Breast Cancer: The FARM Trial.
     Ann Surg Oncol. 2025 Jun 23. doi: 10.1245/s10434-025-17703.
     PubMed     Abstract available
     
     
     
119. NIERENBERG TC, Plichta JK
     ASO Author Reflections: Adjuvant Therapy Options for Older Women with Early Stage Breast Cancer.
     Ann Surg Oncol. 2025 Jun 23. doi: 10.1245/s10434-025-17732.
     PubMed    
     
     
     
120. HSIEH YC, Huang CS, Chan YH
     A Dose-Image Optimization Trial for Voluven(R)-Assisted Indocyanine Green Fluorescence-Guided Breast Cancer Sentinel Lymph Node Surgery.
     Ann Surg Oncol. 2025 Jun 23. doi: 10.1245/s10434-025-17696.
     PubMed     Abstract available
     
     
     
121. YAO J, Li H, Wang H, Liu B, et al
     Lymphatic Contrast-enhanced Ultrasound as a Noninvasive Predictor of Sentinel Lymph Node Metastasis in Breast Cancer: A Prospective Diagnostic Study.
     Ann Surg Oncol. 2025 Jun 23. doi: 10.1245/s10434-025-17705.
     PubMed     Abstract available
     
     
     
122. OSHI M, Ghasemi F, Yamada A, Yan L, et al
     Activated Hippo Pathway is Associated with a Worse Response to Trastuzumab and Worse Survival in HER2-Positive Breast Cancer.
     Ann Surg Oncol. 2025 Jun 21. doi: 10.1245/s10434-025-17657.
     PubMed     Abstract available
     
     
     
123. JANSEN BAM, Kelder JC, Borchert T, van Uden DJP, et al
     Trends in Surgical Treatment for cT4 Breast Cancer After Neoadjuvant Systemic Therapy: A Nationwide Study in The Netherlands.
     Ann Surg Oncol. 2025 Jun 18. doi: 10.1245/s10434-025-17585.
     PubMed     Abstract available
     
     
     
124. KNOEDLER S, Jiang J, Moog P, Wirtz JM, et al
     ASO Author Reflections: Frailty as a Predictor in Breast Cancer Surgery: Yesterday's Lessons, Today's Evidence, Tomorrow's Potential.
     Ann Surg Oncol. 2025 Jun 17. doi: 10.1245/s10434-025-17604.
     PubMed    
     
     
     
125. HOLT LR, Shern TP, Ozmen T
     ASO Author Reflections: Personalizing Tumor Size Assessment in Breast Cancer-A Framework for Dynamic, Patient-Centered Estimation.
     Ann Surg Oncol. 2025 Jun 17. doi: 10.1245/s10434-025-17701.
     PubMed    
     
     
     
126. KOHLI K, Wang S, Thaploo A, Ho FDV, et al
     ASO Author Reflections: Breast Cancer Among Asian American, Native Hawaiian, and Pacific Islander Patients.
     Ann Surg Oncol. 2025 Jun 16. doi: 10.1245/s10434-025-17510.
     PubMed    
     
     
     
127. JUNG JJ, Kim HC, Kang E, Kim HK, et al
     Refining Criteria for Axillary Surgery Omission After Neoadjuvant Systemic Therapy in Breast Cancer.
     Ann Surg Oncol. 2025 Jun 12. doi: 10.1245/s10434-025-17618.
     PubMed    
     
     
     
128. YOON IC, Perez-Rojas S, Ancha B, Elmore LC, et al
     ASO Visual Abstract: Association of Neighborhood Deprivation with Stage at Diagnosis and Treatment Delay for Breast Cancer in Philadelphia.
     Ann Surg Oncol. 2025 Jun 11. doi: 10.1245/s10434-025-17524.
     PubMed    
     
     
     
129. AHMED S, Manghelli J, Fisher CS, Imeokparia FO, et al
     Effect of Delayed Axillary Lymph Node Dissection on Success Rates of Immediate Lymphatic Reconstruction in Breast Cancer.
     Ann Surg Oncol. 2025 Jun 10. doi: 10.1245/s10434-025-17641.
     PubMed    
     
     
     
130. THILL M, Ghilli M, Roncella M, Kelling K, et al
     ASO Visual Abstract: Multi-Institutional Study to Evaluate the Effectiveness and Safety of a Supine MRI-Based Guidance System, the Breast Cancer Locator(TM), for Breast-Conserving Surgery in Patients with Nonpalpable Breast Cancer.
     Ann Surg Oncol. 2025 Jun 9. doi: 10.1245/s10434-025-17622.
     PubMed    
     
     
     
131. EAGLEHOUSE YL, Darmon S, Nealeigh M, Koehlmoos T, et al
     ASO Visual Abstract: Short-Term Outcomes of Breast Cancer Surgery by Race-Ethnicity in the Military Health System.
     Ann Surg Oncol. 2025 Jun 7. doi: 10.1245/s10434-025-17628.
     PubMed    
     
     
     
132. NIERENBERG TC, Crowell KA, Wang T, Rosenberger LH, et al
     ASO Visual Abstract: Adjuvant Radiation Versus Endocrine Therapy After Lumpectomy for Early Stage Breast Cancer in Older Women-Analysis of Real-World Survival Outcomes.
     Ann Surg Oncol. 2025 Jun 7. doi: 10.1245/s10434-025-17624.
     PubMed    
     
     
     
133. THILL M, Ghilli M, Roncella M, Kelling K, et al
     A Multi-institutional Study to Evaluate the Effectiveness and Safety of a Supine MRI-Based Guidance System, the Breast Cancer Locator(TM), for Breast Conserving Surgery in Patients with Nonpalpable Breast Cancer.
     Ann Surg Oncol. 2025 Jun 6. doi: 10.1245/s10434-025-17513.
     PubMed     Abstract available
     
     
     
134. NIERENBERG TC, Crowell KA, Wang T, Rosenberger LH, et al
     Adjuvant Radiation vs Endocrine Therapy After Lumpectomy for Early-Stage Breast Cancer in Older Women: Analysis of Real-World Survival Outcomes.
     Ann Surg Oncol. 2025 Jun 6. doi: 10.1245/s10434-025-17532.
     PubMed     Abstract available
     
     
     
135. FLANAGAN MR, van den Bruele AMB, Downs-Canner SM, Thomas SM, et al
     ASO Visual Abstract: A Multi-institutional Analysis of Contralateral Axillary Metastases-Advanced Local-Regional Disease Divergent from Stage IV Breast Cancer.
     Ann Surg Oncol. 2025 Jun 3. doi: 10.1245/s10434-025-17563.
     PubMed    
     
     
     
136. HOSANG KM, Bleicher RJ, Yao KA, Dietz JR, et al
     Low Socioeconomic Status at the Patient and Institutional Level Impact Achievement of Breast Cancer Quality Standards.
     Ann Surg Oncol. 2025 Jun 2. doi: 10.1245/s10434-025-17529.
     PubMed     Abstract available
     
     
     
137. VAN DEN BRUELE AB, Rosenberger LH, Downs-Canner S, Flanagan MR, et al
     ASO Author Reflections: Contralateral Axillary Lymph Node Metastasis of Breast Cancer: Time to Re-evaluate Conventional Thinking.
     Ann Surg Oncol. 2025 Jun 2. doi: 10.1245/s10434-025-17535.
     PubMed    
     
     
     
138. LAVA CX, Harish V, Kapp K, Li KR, et al
     Utility of Surgical Axillary Staging in Microinvasive Ductal Carcinoma In Situ: A National Cancer Database Analysis.
     Ann Surg Oncol. 2025;32:4023-4033.
     PubMed     Abstract available
     
     
     
139. BHADOURIYA R, Mantena RV, Selvakumar JP, Yadav P, et al
     Disparities in Refusal of Adjuvant Radiation for Breast-Conserving Therapy in the USA.
     Ann Surg Oncol. 2025;32:4034-4040.
     PubMed     Abstract available
     
     
     
140. WEISS A, Rosito MS, Braun D, Barton B, et al
     Impact of the American Society of Breast Surgeons' Guidelines on Genetic Testing and Contralateral Prophylactic Mastectomy Rates.
     Ann Surg Oncol. 2025;32:3965-3974.
     PubMed     Abstract available
     
     
     
141. KIM E, Dossett LA, Hughes TM, Jeruss JS, et al
     The Effectiveness of Superparamagnetic Iron Oxide Nanoparticles in Reducing Unnecessary Sentinel Lymph Node Biopsies.
     Ann Surg Oncol. 2025;32:4017-4022.
     PubMed     Abstract available
     
     
     
142. SPAULDING S, Orzechowski K, Patek K
     Integration of a Genetic Counselor into a Breast Health Center Improves Identification of Patients Needing Genetic Testing.
     Ann Surg Oncol. 2025;32:4002-4007.
     PubMed     Abstract available
     
     
     
143. NGUYEN AT, Duckworth E, Kandi L, Li RA, et al
     Disparities in Postmastectomy Breast Reconstruction Among American Indian and Alaska Native Women: A Systematic Literature Review and Meta-analysis.
     Ann Surg Oncol. 2025;32:4041-4052.
     PubMed     Abstract available
     
     
     May 2025
144. SAH R, Mathur A, Veldi VDK
     Letter to the Editor Regarding "Differential Effects of Endocrine Therapy Type on Quality of Life in Older (>/= 70 Years) Women with Early-Stage Breast Cancer".
     Ann Surg Oncol. 2025 May 31. doi: 10.1245/s10434-025-17593.
     PubMed    
     
     
     
145. SILVERSTEIN MJ, Kim B, Lin K, Lloyd S, et al
     Intraoperative Radiation Therapy (IORT) for Breast Cancer: The Final Analysis of a Prospective Cohort of 1828 Cases.
     Ann Surg Oncol. 2025 May 31. doi: 10.1245/s10434-025-17546.
     PubMed     Abstract available
     
     
     
146. ORSI C, Davis T, Swindall R, Wadle C, et al
     ASO Visual Abstract: Disparities in Timeliness of Breast Cancer Treatment in a Rural Setting; Rural Breast Cancer Treatment Disparities.
     Ann Surg Oncol. 2025 May 30. doi: 10.1245/s10434-025-17476.
     PubMed    
     
     
     
147. WEISS A, Agnese DM, Al-Hilli Z, Cabioglu N, et al
     Correction: An Overview of the Importance of Neoadjuvant Systemic Therapy for Breast Cancer Patients: From the Society of Surgical Oncology and the American Society of Breast Surgeons.
     Ann Surg Oncol. 2025 May 21. doi: 10.1245/s10434-025-17580.
     PubMed    
     
     
     
148. EAGLEHOUSE YL, Darmon S, Nealeigh M, Koehlmoos T, et al
     Short-Term Outcomes of Breast Cancer Surgery by Race-Ethnicity in the Military Health System.
     Ann Surg Oncol. 2025 May 21. doi: 10.1245/s10434-025-17449.
     PubMed     Abstract available
     
     
     
149. FLANAGAN MR, van den Bruele AMB, Downs-Canner SM, Thomas SM, et al
     A Multi-Institutional Analysis of Contralateral Axillary Metastases: Advanced Local-Regional Disease Divergent from Stage IV Breast Cancer.
     Ann Surg Oncol. 2025 May 20. doi: 10.1245/s10434-025-17406.
     PubMed     Abstract available
     
     
     
150. WU C, Zhao H, Di H, Cheng K, et al
     ASO Author Reflections: Global Research Status of Breast Cancer Stem Cells.
     Ann Surg Oncol. 2025 May 17. doi: 10.1245/s10434-025-17457.
     PubMed    
     
     
     
151. ZOU Y, Bian L, Zhang H, Tang H, et al
     ASO Author Reflections: Limited Survival Benefit from Neoadjuvant Chemotherapy in ER+/HER2- Breast Cancer.
     Ann Surg Oncol. 2025 May 17. doi: 10.1245/s10434-025-17408.
     PubMed    
     
     
     
152. KNOEDLER S, Jiang J, Moog P, Wirtz JM, et al
     Predicting Outcomes of Breast-Conserving Surgery in Patients with Breast Cancer Using the Modified 5-Item Frailty Index: A Retrospective Cohort Study.
     Ann Surg Oncol. 2025 May 16. doi: 10.1245/s10434-025-17438.
     PubMed     Abstract available
     
     
     
153. WEISS A, Agnese DM, Al-Hilli Z, Cabioglu N, et al
     An Overview of the Importance of Neoadjuvant Systemic Therapy for Breast Cancer Patients.
     Ann Surg Oncol. 2025 May 12. doi: 10.1245/s10434-025-17405.
     PubMed    
     
     
     
154. YOON IC, Perez-Rojas S, Ancha B, Elmore LC, et al
     Association of Neighborhood Deprivation with Stage at Diagnosis and Treatment Delay for Breast Cancer in Philadelphia.
     Ann Surg Oncol. 2025 May 12. doi: 10.1245/s10434-025-17367.
     PubMed     Abstract available
     
     
     
155. KOUZMINA E, Castelo M, Look Hong NJ, Hallet J, et al
     ASO Visual Abstract: Axillary Surgery After Neoadjuvant Chemotherapy for Breast Cancer-Population-Based Trends over Time.
     Ann Surg Oncol. 2025 May 10. doi: 10.1245/s10434-025-17423.
     PubMed    
     
     
     
156. DENNIS S, Tsukioki T, Kocherginsky M, Qi AK, et al
     ASO Visual Abstract: Neoadjuvant Chemotherapy Response and Genetic Susceptibility in Recently Parous Women with Breast Cancer: A Retrospective Analysis.
     Ann Surg Oncol. 2025 May 8. doi: 10.1245/s10434-025-17370.
     PubMed    
     
     
     
157. CHO MJ, Chratian S, Hansotia K, Skoracki R, et al
     Reply to: "Prophylactic Lymphovenous Bypass for Breast Cancer-Related Lymphedema: Research Challenges, Statistical Pitfalls, and Solutions".
     Ann Surg Oncol. 2025 May 2. doi: 10.1245/s10434-025-17377.
     PubMed    
     
     
     
158. ROBERTS A, Campbell AC, Pollack BL, Montagna G, et al
     Racial and Ethnic Differences in Breast Inflammation and Its Association with Lymphedema Risk After Axillary Lymph Node Dissection.
     Ann Surg Oncol. 2025;32:3309-3316.
     PubMed     Abstract available
     
     
     
159. WARREN YE JR, Stead TS, Tomlinson-Hansen S, Stuckey AR, et al
     Outcomes in Women Undergoing Combined Breast, Plastic, and Gynecologic Surgery.
     Ann Surg Oncol. 2025;32:3302-3308.
     PubMed     Abstract available
     
     
     
160. ZAVERI S, Sun SX, Zaghloul T, Bevers TB, et al
     Trends in Atypical Ductal Hyperplasia Diagnosis and Upgrade: A 20-Year Experience and Impact of MRI Use on Upgrade Rates.
     Ann Surg Oncol. 2025;32:3244-3251.
     PubMed     Abstract available
     
     
     
161. JAVID SH, Kazerouni AS, Hippe DS, Hirano M, et al
     Preoperative MRI to Predict Upstaging of DCIS to Invasive Cancer at Surgery.
     Ann Surg Oncol. 2025;32:3234-3243.
     PubMed     Abstract available
     
     
     
162. TAKAYESU JSK, Baglien B, Edwards D, Marsh R, et al
     Effect of Prepectoral Versus Subpectoral Implant-Based Reconstruction on Post-Mastectomy Radiation Dosimetry.
     Ann Surg Oncol. 2025;32:3705-3712.
     PubMed     Abstract available
     
     
     
163. ROCHLIN DH, Wang Y, Amakiri UO, Levy J, et al
     Lower Commercial Rates for Breast Surgical Procedures are Associated with Socioeconomic Disadvantage: A Transparency in Coverage Analysis.
     Ann Surg Oncol. 2025;32:3695-3704.
     PubMed     Abstract available
     
     
     April 2025
164. LI K, Moshier E, Shao T, Rosenstein BS, et al
     Differential Effects of Endocrine Therapy Type on Quality of Life in Older (>/=70 Years) Women with Early-Stage Breast Cancer.
     Ann Surg Oncol. 2025 Apr 26. doi: 10.1245/s10434-024-16482.
     PubMed     Abstract available
     
     
     
165. SATO T, Hagerty BL, Wu R, Ishikawa T, et al
     ASO Author Reflections: Is Mesothelin a Promising Option for Molecular Targeted Therapies in Triple Negative Breast Cancer?
     Ann Surg Oncol. 2025 Apr 24. doi: 10.1245/s10434-025-17314.
     PubMed    
     
     
     
166. CHENG K, Di H, Wu C, Zhao H, et al
     Mapping Knowledge Landscapes and Themes Trends of Breast Cancer Stem Cells: A Comprehensive Data-Mining-Based Study.
     Ann Surg Oncol. 2025 Apr 23. doi: 10.1245/s10434-025-17336.
     PubMed     Abstract available
     
     
     
167. WANG J, Yang B, Bian L, Zhang H, et al
     Long-term Outcomes for Neoadjuvant Versus Adjuvant Chemotherapy in ER+/HER2- Locally Advanced Breast Cancer.
     Ann Surg Oncol. 2025 Apr 22. doi: 10.1245/s10434-025-17297.
     PubMed     Abstract available
     
     
     
168. DOUGLAS SR, Margenthaler JA, McGuire KP, Hwang ES, et al
     Great Debate: Does Breast-Conserving Surgery with Radiotherapy Offer Better Survival than Mastectomy in Early-Stage Breast Cancer?
     Ann Surg Oncol. 2025 Apr 21. doi: 10.1245/s10434-025-17333.
     PubMed    
     
     
     
169. HAGERTY BL, Sato T, Wu R, Ishikawa T, et al
     ASO Visual Abstract: Mesothelin (MSLN) is Highly Expressed in Triple-Negative Breast Cancer and is Associated with Enhanced Cell Proliferation and Pro-inflammatory Tumor Microenvironment.
     Ann Surg Oncol. 2025 Apr 21. doi: 10.1245/s10434-025-17253.
     PubMed    
     
     
     
170. BOYLE MK, Giuliano AE
     ASO Author Reflections: Advances in Axillary Management for Breast Cancer After Neoadjuvant Chemotherapy.
     Ann Surg Oncol. 2025 Apr 20. doi: 10.1245/s10434-025-17340.
     PubMed    
     
     
     
171. ORSI C, Davis T, Swindall R, Wadle C, et al
     Disparities in Timeliness of Breast Cancer Treatment in a Rural Setting: Breast Cancer Treatment Disparities.
     Ann Surg Oncol. 2025 Apr 17. doi: 10.1245/s10434-025-17291.
     PubMed     Abstract available
     
     
     
172. DENNIS S, Tsukioki T, Kocherginsky M, Qi AK, et al
     Neoadjuvant Chemotherapy Response and Genetic Susceptibility in Recently Parous Women with Breast Cancer: A Retrospective Analysis.
     Ann Surg Oncol. 2025 Apr 9. doi: 10.1245/s10434-025-17204.
     PubMed     Abstract available
     
     
     
173. KOUZMINA E, Castelo M, Look Hong NJ, Hallet J, et al
     Axillary Surgery After Neoadjuvant Chemotherapy for Breast Cancer: Population-Based Trends Over Time.
     Ann Surg Oncol. 2025 Apr 4. doi: 10.1245/s10434-025-17236.
     PubMed     Abstract available
     
     
     
174. CHIARELLA LS, Huelsboemer L, Diatta F, Klimitz FJ, et al
     ASO Author Reflections: The Five-Item Modified Frailty Index in Breast Cancer Surgery: Past Insights, Present Evidence, and Future Directions.
     Ann Surg Oncol. 2025 Apr 4. doi: 10.1245/s10434-025-17273.
     PubMed    
     
     
     
175. PERRY LM, Sevilimedu V, Polidorio N, Abuhadra N, et al
     ASO Visual Abstract: Predictors of Pathologic Complete Response with Neoadjuvant Chemo-Immunotherapy in Early-Stage Triple-Negative Breast Cancer.
     Ann Surg Oncol. 2025 Apr 2. doi: 10.1245/s10434-025-17248.
     PubMed    
     
     
     
176. PASCHALIS K, Marin C, Miller K, Regis C, et al
     Patients with DCIS Seen at a Specialized High-Risk Breast Clinic Run by Surgical Advanced Practice Providers Have High Rates of Preventive Medication Uptake.
     Ann Surg Oncol. 2025;32:2526-2533.
     PubMed     Abstract available
     
     
     
177. SWAFFORD EP, Anantha S, Davis J, Heath R, et al
     Lumpectomy Patients are at Highest Risk for Opioid Overprescription: A Comparison Between Practice Patterns and OPEN National Guidelines.
     Ann Surg Oncol. 2025;32:2585-2593.
     PubMed     Abstract available
     
     
     
178. NAKHLIS F, Baker GM, Li T, McAuliffe PF, et al
     Incidence of Adjacent Synchronous Ipsilateral Infiltrating Carcinoma and/or Ductal Carcinoma In Situ in Patients Diagnosed with Flat Epithelial Atypia by Core Needle Biopsy (TBCRC 034).
     Ann Surg Oncol. 2025;32:2578-2584.
     PubMed     Abstract available
     
     
     
179. VERDIAL FC, Anderman KJ, Daly AE, Ozmen T, et al
     The Age-Old Question in Nipple-Sparing Mastectomy: Is Older Age a Contraindication?
     Ann Surg Oncol. 2025;32:2569-2577.
     PubMed     Abstract available
     
     
     
180. MEURS CJC, Kerkhoven C, Siesling S, Menke-Pluijmers MBE, et al
     Surgery for Classic, Pleomorphic and Non-classic Lobular Carcinoma In Situ: Surgery Rate, Risk of Upstaging and Short-Term Follow-Up.
     Ann Surg Oncol. 2025;32:2545-2553.
     PubMed     Abstract available
     
     
     
181. CHEN Z, Zhang J, Chen W, Chen X, et al
     ASO Author Reflections: Serum Enzymes as Predictive Biomarkers for Pathologic Complete Response in HER2-Positive Breast Cancer.
     Ann Surg Oncol. 2025 Apr 1. doi: 10.1245/s10434-025-17259.
     PubMed    
     
     
     March 2025
182. BOYLE MK, Amersi F, Chung A, Tseng J, et al
     Comparison of Targeted Axillary Dissection with Sentinel Node Biopsy Alone on Nodal Recurrence for Patients who have Node-Positive Breast Cancer Treated with Neoadjuvant Chemotherapy.
     Ann Surg Oncol. 2025 Mar 25. doi: 10.1245/s10434-025-17197.
     PubMed     Abstract available
     
     
     
183. THAPLOO A, Kohli K, Wang S, Ho FDV, et al
     ASO Visual Abstract: Disparities in Stage at Presentation for Disaggregated Asian American, Native Hawaiian, and Pacific Islander Patients with Breast Cancer.
     Ann Surg Oncol. 2025 Mar 24. doi: 10.1245/s10434-025-17133.
     PubMed    
     
     
     
184. CHEN Z, Zhang J, Chen W, Chen X, et al
     ASO Visual Abstract: Serum Enzymes and Pathologic Complete Response to the Addition of Targeted Therapy in Neoadjuvant Chemotherapy for HER2-Positive Breast Cancer Patients.
     Ann Surg Oncol. 2025 Mar 24. doi: 10.1245/s10434-025-17243.
     PubMed    
     
     
     
185. LORENTZEN EH, Nguyen K, Chen YJ, King TA, et al
     Downstream Effects of Omission of Axillary Surgery in Older Adults with Early-Stage HR+/HER2- Breast Cancer.
     Ann Surg Oncol. 2025 Mar 21. doi: 10.1245/s10434-025-17196.
     PubMed     Abstract available
     
     
     
186. PITSINIS V, Benson J
     Reply to: Letter to the Editor in Relation to 'Results of a Prospective Randomized Multicentre Study Comparing Indocyanine Green (ICG) Fluorescence Combined with a Standard Tracer Versus ICG Alone for Sentinel Lymph Node Biopsy in Early Breast Cancer:
     Ann Surg Oncol. 2025 Mar 21. doi: 10.1245/s10434-025-17158.
     PubMed    
     
     
     
187. KARAMITROS G, Grant MP, Lamaris GA
     Prophylactic Lymphovenous Bypass for Breast Cancer-Related Lymphedema: Research Challenges, Statistical Pitfalls, and Solutions.
     Ann Surg Oncol. 2025 Mar 18. doi: 10.1245/s10434-025-17200.
     PubMed    
     
     
     
188. HAGERTY BL, Sato T, Wu R, Ishikawa T, et al
     Mesothelin (MSLN) is Highly Expressed in Triple Negative Breast Cancer and is Associated with Enhanced Cell Proliferation and Proinflammatory Tumor Microenvironment.
     Ann Surg Oncol. 2025 Mar 13. doi: 10.1245/s10434-025-17117.
     PubMed     Abstract available
     
     
     
189. OZCAN BB, Arjmandi FK, Polat DS, Xi Y, et al
     ASO Visual Abstract: Factors Associated with Nodal Positivity Following Neoadjuvant Therapy in Breast Cancer Patients Who are Initially Node-Negative on MRI.
     Ann Surg Oncol. 2025 Mar 13. doi: 10.1245/s10434-025-17137.
     PubMed    
     
     
     
190. CHEN Z, Zhang J, Chen W, Chen X, et al
     Serum Enzymes and Pathologic Complete Response to the Addition of Targeted Therapy in Neoadjuvant Chemotherapy for HER2-Positive Breast Cancer Patients.
     Ann Surg Oncol. 2025 Mar 11. doi: 10.1245/s10434-025-17110.
     PubMed     Abstract available
     
     
     
191. FLESHNER K, Quan ML
     ASO Author Reflections: Uptake of Completion Axillary Lymph Node Dissection in Post-Neoadjuvant Chemotherapy Breast Cancer Patients.
     Ann Surg Oncol. 2025 Mar 8. doi: 10.1245/s10434-025-17129.
     PubMed    
     
     
     
192. DOGAN B
     ASO Author Reflections: Sentinel Lymph Node Biopsy in Node-Negative Breast Cancer Patients Treated with Neoadjuvant Chemotherapy: Considerations and Emerging Evidence.
     Ann Surg Oncol. 2025 Mar 7. doi: 10.1245/s10434-025-17126.
     PubMed    
     
     
     
193. YOUNG J, Asaoka M, Ghasemi F, Chida K, et al
     ASO Visual Abstract: The American Joint Committee on Cancer (AJCC) Breast Cancer Staging 8th Edition is More Reflective of Cancer Biology Than the 7th Edition.
     Ann Surg Oncol. 2025 Mar 6. doi: 10.1245/s10434-025-17065.
     PubMed    
     
     
     
194. PERRY LM, Sevilimedu V, Polidorio N, Abuhadra N, et al
     Predictors of Pathologic Complete Response with Neoadjuvant Chemo-Immunotherapy in Early-Stage Triple-Negative Breast Cancer.
     Ann Surg Oncol. 2025 Mar 2. doi: 10.1245/s10434-025-17081.
     PubMed     Abstract available
     
     
     
195. GAU RY, Chou HH, Tsai HP, Shen SC, et al
     Long-Term Follow-Up of Surgical Outcomes and Oncological Results of Nipple-Sparing Mastectomy with Immediate Reconstruction Through a Single Axillary Incision with Different Approach Methods.
     Ann Surg Oncol. 2025;32:2092-2102.
     PubMed     Abstract available
     
     
     
196. HEELING E, Kramer GM, Volders JH, van Bommel ACM, et al
     Increasing Rates but Persistent Variability of Immediate Breast Reconstruction: Real-Time Data from a Population-Based Study (2012-2022).
     Ann Surg Oncol. 2025;32:1997-2006.
     PubMed     Abstract available
     
     
     
197. THAPLOO A, Kohli K, Wang S, Ho FDV, et al
     Disparities in Stage at Presentation for Disaggregated Asian American, Native Hawaiian, and Pacific Islander Patients with Breast Cancer.
     Ann Surg Oncol. 2025 Mar 1. doi: 10.1245/s10434-025-16974.
     PubMed     Abstract available
     
     
     February 2025
198. BOROWSKY PA, Hernandez AE, Kesmodel SB, Goel N, et al
     Genetic Ancestry and 21-Gene Oncotype DX Breast Cancer Recurrence Scores.
     Ann Surg Oncol. 2025 Feb 27. doi: 10.1245/s10434-025-17012.
     PubMed     Abstract available
     
     
     
199. FLESHNER K, Xu Y, Isherwood S, Yang F, et al
     Real-World Assessment of Locoregional Management of the Axilla in Node-Positive Breast Cancer After Neoadjuvant Chemotherapy.
     Ann Surg Oncol. 2025 Feb 19. doi: 10.1245/s10434-025-17041.
     PubMed     Abstract available
     
     
     
200. CABIOGLU N, Karanlik H, Igci A, Muslumanoglu M, et al
     ASO Visual Abstract: Breast Cancer Recurrence in Initially Clinically Node-Positive Patients Undergoing Sentinel Lymph Node Biopsy after Neoadjuvant Chemotherapy in the NEOSENTITURK-trials MF18-02/18-03.
     Ann Surg Oncol. 2025 Feb 18. doi: 10.1245/s10434-024-16746.
     PubMed    
     
     
     
201. KITAI T, Yamanaka K
     Letter to the Editor in Relation to "Results of a Prospective Randomized Multicenter Study Comparing Indocyanine Green (ICG) Fluorescence Combined with a Standard Tracer Versus ICG Alone for Sentinel Lymph Node Biopsy in Early Breast Cancer: The INFLU
     Ann Surg Oncol. 2025 Feb 14. doi: 10.1245/s10434-025-17016.
     PubMed    
     
     
     
202. OZCAN BB, Arjmandi FK, Polat DS, Xi Y, et al
     Factors Associated with Nodal Positivity Following Neoadjuvant Systemic Therapy in Breast Cancer Patients Who are Initially Node-Negative on MRI.
     Ann Surg Oncol. 2025 Feb 13. doi: 10.1245/s10434-025-16985.
     PubMed     Abstract available
     
     
     
203. BOUGHEY JC, Yu H, Switalla K, Velle L, et al
     Oncologic Outcomes with De-Escalation of Axillary Surgery After Neoadjuvant Chemotherapy for Breast Cancer: Results from > 1500 Patients on the I-SPY2 Clinical Trial.
     Ann Surg Oncol. 2025 Feb 13. doi: 10.1245/s10434-025-16973.
     PubMed     Abstract available
     
     
     
204. REDDY KP, Fayanju OM
     ASO Author Reflections: The Financial Impact of Delayed and Forgone Care Among Patients with Breast Cancer.
     Ann Surg Oncol. 2025 Feb 11. doi: 10.1245/s10434-025-16969.
     PubMed    
     
     
     
205. YOUNG J, Asaoka M, Ghasemi F, Chida K, et al
     The American Joint Committee on Cancer (AJCC) Breast Cancer Staging, Eighth Edition, is more Reflective of Cancer Biology than the Seventh Edition.
     Ann Surg Oncol. 2025 Feb 7. doi: 10.1245/s10434-025-16889.
     PubMed     Abstract available
     
     
     
206. ZHANG M, Yuan L, Cui M, Chen J, et al
     ASO Author Reflections: Personal Insights and Reflections on the Burden of Breast Cancer Among Adolescents and Young Adults.
     Ann Surg Oncol. 2025 Feb 6. doi: 10.1245/s10434-024-16858.
     PubMed    
     
     
     
207. LAWS A, Leonard S, Vincuilla J, Parker T, et al
     ASO Visual Abstract: Risk of Surgical Overtreatment in cN1 Breast Cancer Patients Who Become ypN0 After Neoadjuvant Chemotherapy: SLNB Versus TAD.
     Ann Surg Oncol. 2025 Feb 3. doi: 10.1245/s10434-025-16952.
     PubMed    
     
     
     
208. COLEMAN-BELIN JC, Rubin J, Boe LA, Diwan R, et al
     Protective Factors Associated with Normal Lymphatic Function After Axillary Lymph Node Dissection for Breast Cancer Treatment.
     Ann Surg Oncol. 2025 Feb 3. doi: 10.1245/s10434-025-16918.
     PubMed     Abstract available
     
     
     
209. SINGH P, Agnese DM, Amin M, Barrio AV, et al
     Society of Surgical Oncology Breast Disease Site Working Group Statement on Bilateral Risk-Reducing Mastectomy: Indications, Outcomes, and Risks.
     Ann Surg Oncol. 2025;32:899-911.
     PubMed     Abstract available
     
     
     
210. KHAN MMM, Khalil M, Stecko H, Pawlik TM, et al
     Disparities in Next-Generation Genetic Sequencing Among Individuals with Cancer.
     Ann Surg Oncol. 2025;32:650-652.
     PubMed     Abstract available
     
     
     
211. WINER L, Ruth KJ, Bleicher RJ, Nagarathinam R, et al
     Immunohistochemical Status Predicts Pathologic Complete Response to Neoadjuvant Therapy in HER2-Overexpressing Breast Cancers.
     Ann Surg Oncol. 2025;32:931-943.
     PubMed     Abstract available
     
     
     
212. LIU LL, Lin YK, Xiang ZL
     The Value of Primary Tumor Resection in Patients with Liver Metastases: A 10-Year Outcome.
     Ann Surg Oncol. 2025;32:1083-1092.
     PubMed     Abstract available
     
     
     
213. ESPARHAM A, Shoar S, Whittington J, Shafaee Z, et al
     National Trends and In-Hospital Outcomes for Immediate Implant-Based Versus Autologous-Based Breast Reconstruction: A Propensity Score-Matched Analysis.
     Ann Surg Oncol. 2025;32:985-992.
     PubMed     Abstract available
     
     
     January 2025
214. SCHUMACHER JR, Tucholka JL, Breuer CR, McKinney GH, et al
     Ongoing Symptoms and Concerns Experienced by Low-Risk Breast Cancer Survivors Following Active Treatment.
     Ann Surg Oncol. 2025 Jan 29. doi: 10.1245/s10434-025-16959.
     PubMed     Abstract available
     
     
     
215. NTOWE KW, Lee MS, Yi VN, Kaplan SJ, et al
     ASO Visual Abstract: Short-Term Patient-Reported Outcomes Following Bilateral Risk-Reducing Mastectomy for Patients at High Risk for Breast Cancer: A Systematic Review.
     Ann Surg Oncol. 2025 Jan 23. doi: 10.1245/s10434-025-16902.
     PubMed    
     
     
     
216. REDDY KP, Jarrell K, Berkowitz C, Hulse S, et al
     ASO Visual Abstract: Association Between Delayed/Forgone Medical Care and Resource Utilization Among Women with Breast Cancer in the United States.
     Ann Surg Oncol. 2025 Jan 23. doi: 10.1245/s10434-024-16776.
     PubMed    
     
     
     
217. CHRISTENHUSZ A, Mirzaei N, Karakatsanis A, Eriksson S, et al
     ASO Visual Abstract: Magnetic Sentinel Lymph Node Biopsy in Early Breast Cancer Patients: An Individual Patient Data Meta-Analysis of Tracer Uptake.
     Ann Surg Oncol. 2025 Jan 22. doi: 10.1245/s10434-024-16780.
     PubMed    
     
     
     
218. YI JP, Yoon CI, Lim SH, Choi H, et al
     ASO Visual Abstract: Prognosis of Patients with Breast Cancer Following Delayed Diagnosis During the COVID-19 Pandemic: A Real-World Cohort Study.
     Ann Surg Oncol. 2025 Jan 16. doi: 10.1245/s10434-025-16870.
     PubMed    
     
     
     
219. VAN DEN BRUELE AB, Williams A, Weiss A
     Commentary and Updates on the Management of Male Breast Cancer.
     Ann Surg Oncol. 2025 Jan 13. doi: 10.1245/s10434-024-16756.
     PubMed    
     
     
     
220. CHO MJ, Chratian S, Skoracki R
     ASO Author Reflections: Breast Cancer-Related Lymphedema Prevention: The Impact of Prophylactic Lymphovenous Bypass.
     Ann Surg Oncol. 2025 Jan 12. doi: 10.1245/s10434-024-16824.
     PubMed    
     
     
     
221. FEFFERMAN ML, Thompson DM, Wilke LG, Hwang S, et al
     ASO Visual Abstract: Commission on Cancer Center Performance with the New Breast Cancer Quality Measures: A Review of Historical Data.
     Ann Surg Oncol. 2025 Jan 9. doi: 10.1245/s10434-024-16777.
     PubMed    
     
     
     
222. DARIYA S, Agarwal G
     Letter to the Editor: Guideline-Concordant Surgical Care for Lobular Versus Ductal Inflammatory Breast Cancer.
     Ann Surg Oncol. 2025 Jan 7. doi: 10.1245/s10434-024-16839.
     PubMed    
     
     
     
223. NTOWE KW, Lee MS, Yi VN, Kaplan SJ, et al
     Short-term Patient-Reported Outcomes Following Bilateral Risk-Reducing Mastectomy for Patients at a High Risk for Breast Cancer: A Systematic Review.
     Ann Surg Oncol. 2025 Jan 4. doi: 10.1245/s10434-024-16805.
     PubMed     Abstract available
     
     
     
224. CHO MJ, Senger JL, Park KU, Hansotia K, et al
     ASO Visual Abstract: Preventing Breast Cancer-Related Lymphedema-A Comprehensive Analysis of a 9-Year Single-Center Experience of Prophylactic Lymphovenous Bypass.
     Ann Surg Oncol. 2025 Jan 4. doi: 10.1245/s10434-024-16784.
     PubMed    
     
     
     
225. GIANNAKOU A, Kantor O, Park KU, Waks AG, et al
     ASO Visual Abstract: Real-World Implications of the SOUND Trial.
     Ann Surg Oncol. 2025;32:121-122.
     PubMed     Abstract available
     
     
     
226. KIM M, Amakiri UO, Wong F, Barnett J, et al
     Race and Ethnicity Impacts Patient-Reported Outcomes in Implant-Based Breast Reconstruction.
     Ann Surg Oncol. 2025;32:551-561.
     PubMed     Abstract available
     
     
     
227. KHUBCHANDANI JA, Suttiratana SC, Washington R, White-Bracey D, et al
     Living Flat: Stories from Women of Color After Mastectomy.
     Ann Surg Oncol. 2025;32:104-114.
     PubMed     Abstract available
     
     
     
228. WANG X, Jackson J, Weed C, Boyle MK, et al
     Staged Nipple Delay Procedure Expands Candidacy for Nipple-Sparing Mastectomy.
     Ann Surg Oncol. 2025;32:98-103.
     PubMed     Abstract available
     
     
     
229. MATAR-UJVARY R, Sevilimedu V, Morrow M
     Are Clinically Node-Negative Patients with a Positive Preoperative Axillary Lymph Node Biopsy Appropriate Candidates for Sentinel Lymph Node Biopsy?
     Ann Surg Oncol. 2025;32:92-97.
     PubMed     Abstract available
     
     
     December 2024
230. YANG Z, Wu T, Chen P, Li L, et al
     Recurrence Patterns and Long-Term Results After Curative Surgery for Patients With Breast Cancer.
     Ann Surg Oncol. 2024 Dec 30. doi: 10.1245/s10434-024-16726.
     PubMed     Abstract available
     
     
     
231. SELFRIDGE JM, Schrank Z, Agala CB, Ollila DW, et al
     ASO Visual Abstract: Outcomes and Trends in Axillary Management of Patients with Stage cN3b Breast Cancer.
     Ann Surg Oncol. 2024 Dec 29. doi: 10.1245/s10434-024-16783.
     PubMed    
     
     
     
232. CHO MJ, Senger JL, Park KU, Hansotia K, et al
     Preventing Breast Cancer-Related Lymphedema: A Comprehensive Analysis of a 9-Year Single-Center Experience of Prophylactic Lymphovenous Bypass.
     Ann Surg Oncol. 2024 Dec 23. doi: 10.1245/s10434-024-16640.
     PubMed     Abstract available
     
     
     
233. CHRISTENHUSZ A, Mirzaei N, Warnberg F, Alic L, et al
     ASO Author Reflections: Redefining Precision-Insights into Magnetic Sentinel Lymph Node Biopsy for Early Breast Cancer.
     Ann Surg Oncol. 2024 Dec 21. doi: 10.1245/s10434-024-16725.
     PubMed    
     
     
     
234. KANG YJ, Yi JP, Yoon CI
     ASO Author Reflections: Hidden Impact of COVID-19 on Breast Cancer Outcomes: Lessons From South Korea.
     Ann Surg Oncol. 2024 Dec 21. doi: 10.1245/s10434-024-16721.
     PubMed    
     
     
     
235. REDDY KP, Jarrell K, Berkowitz C, Hulse S, et al
     Association Between Delayed/Forgone Medical Care and Resource Utilization Among Women with Breast Cancer in the United States.
     Ann Surg Oncol. 2024 Dec 18. doi: 10.1245/s10434-024-16586.
     PubMed     Abstract available
     
     
     
236. SCHRANK Z, Selfridge JM
     ASO Author Reflections: Can Axillary Lymph Node Dissection be Safely Avoided for Some Stage cN3b Breast Cancer Patients?
     Ann Surg Oncol. 2024 Dec 18. doi: 10.1245/s10434-024-16724.
     PubMed    
     
     
     
237. TAHTASAKAL R, Hamurcu Z, Oz AB, Balli M, et al
     miR-484 as an "OncomiR" in Breast Cancer Promotes Tumorigenesis by Suppressing Apoptosis Genes.
     Ann Surg Oncol. 2024 Dec 18. doi: 10.1245/s10434-024-16656.
     PubMed     Abstract available
     
     
     
238. CHRISTENHUSZ A, Mirzaei N, Karakatsanis A, Eriksson S, et al
     Magnetic Sentinel Lymph Node Biopsy in Early Breast Cancer Patients: An Individual Patient Data Meta-analysis of Tracer Uptake.
     Ann Surg Oncol. 2024 Dec 17. doi: 10.1245/s10434-024-16626.
     PubMed     Abstract available
     
     
     
239. SELFRIDGE JM, Schrank Z, Agala CB, Ollila DW, et al
     Outcomes and Trends in Axillary Management of Stage cN3b Breast Cancer Patients.
     Ann Surg Oncol. 2024 Dec 14. doi: 10.1245/s10434-024-16630.
     PubMed     Abstract available
     
     
     
240. ZHANG M, Yuan L, Cui M, Chen J, et al
     Analysis the Burden of Breast Cancer Among Adolescents and Young Adults Using the Global Burden of Disease 2021.
     Ann Surg Oncol. 2024 Dec 12. doi: 10.1245/s10434-024-16648.
     PubMed     Abstract available
     
     
     
241. FEFFERMAN ML, Thompson DM, Wilke LG, Hwang S, et al
     Commission on Cancer Center Performance with the New Breast Cancer Quality Measures: A Review of Historical Data.
     Ann Surg Oncol. 2024 Dec 10. doi: 10.1245/s10434-024-16594.
     PubMed     Abstract available
     
     
     
242. PANG J, Ding N, Liu X, He X, et al
     ASO Author Reflections: Reflections on the Role of the Systemic Immune-Inflammation Index in Prognostic Assessment in HER2-Positive Metastatic Breast Cancer.
     Ann Surg Oncol. 2024 Dec 10. doi: 10.1245/s10434-024-16664.
     PubMed    
     
     
     
243. REH N, Caston NE, Williams CP, Dwarampudi SR, et al
     Therapeutic Clinical Trial Eligibility and Enrollment among Women with Breast Cancer: Implications for Understanding Trial Disparities.
     Ann Surg Oncol. 2024 Dec 9. doi: 10.1245/s10434-024-16607.
     PubMed     Abstract available
     
     
     
244. CABIOGLU N, Karanlik H, Igci A, Muslumanoglu M, et al
     ASO Author Reflections: Nodal Recurrence Is Rare in Patients with cN+/ycN0 Breast Cancer after Neoadjuvant Chemotherapy Regardless of the Extent of Axillary Surgery or Nodal Pathology in the NEOSENTITURK-Trials MF18-02/18-03 Provided Regional Nodal Ir
     Ann Surg Oncol. 2024 Dec 9. doi: 10.1245/s10434-024-16651.
     PubMed     Abstract available
     
     
     
245. SHIM V, Karlea A, Brenman LM, Gul J, et al
     ASO Visual Abstract: Impact of Mainstream Germline Genetic Testing with Expanded Eligibility for Early Stage Breast Cancer Patients in a Large Integrated Health System.
     Ann Surg Oncol. 2024 Dec 4. doi: 10.1245/s10434-024-16559.
     PubMed    
     
     
     
246. YI JP, Yoon CI, Lim SH, Choi H, et al
     Prognosis of Patients with Breast Cancer Following Delayed Diagnosis During the COVID-19 Pandemic: A Real-World Cohort Study.
     Ann Surg Oncol. 2024 Dec 4. doi: 10.1245/s10434-024-16645.
     PubMed     Abstract available
     
     
     
247. LAWS A, Leonard S, Vincuilla J, Parker T, et al
     Risk of Surgical Overtreatment in cN1 Breast Cancer Patients who Become ypN0 After Neoadjuvant Chemotherapy: SLNB Versus TAD.
     Ann Surg Oncol. 2024 Dec 4. doi: 10.1245/s10434-024-16625.
     PubMed     Abstract available
     
     
     
248. WINER LK, Williams AD
     ASO Author Reflections: Beyond the Binary: Using IHC Status to Predict Response to Neoadjuvant Therapy in HER2+ Early-Stage Breast Cancer.
     Ann Surg Oncol. 2024 Dec 2. doi: 10.1245/s10434-024-16606.
     PubMed    
     
     
     
249. CABIOGLU N, Karanlik H, Igci A, Muslumanoglu M, et al
     Breast Cancer Recurrence in Initially Clinically Node-Positive Patients Undergoing Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in the NEOSENTITURK-Trials MF18-02/18-03.
     Ann Surg Oncol. 2024 Dec 2. doi: 10.1245/s10434-024-16472.
     PubMed     Abstract available
     
     
     
250. GIANNAKOU A, Kantor O, Park KU, Waks AG, et al
     Real-World Implications of the SOUND Trial.
     Ann Surg Oncol. 2024;31:8776-8785.
     PubMed     Abstract available
     
     
     
251. WOESTE MR, Jacob K, Shindorf M, Gaskins JT, et al
     Identifying Factors Predicting Margin Status After Mastectomy.
     Ann Surg Oncol. 2024;31:8882-8890.
     PubMed     Abstract available
     
     
     
252. ECKERT KM, Hoskin TL, Olson CA, Goetz MP, et al
     In-Breast Tumor Progression During Neoadjuvant Chemotherapy: Impact on and Factors Influencing Distant Recurrence-Free Survival.
     Ann Surg Oncol. 2024;31:8856-8865.
     PubMed     Abstract available
     
     
     
253. DISKIN B, Sevilimedu V, Morrow M, Van Zee K, et al
     Management of Ipsilateral Breast Tumor Recurrence Following Breast Conservation Surgery for Ductal Carcinoma In Situ: A Data-Poor Zone.
     Ann Surg Oncol. 2024;31:8843-8847.
     PubMed     Abstract available
     
     
     
254. DEY P, Kc M, Proussaloglou EM, Khubchandani JA, et al
     Incidence of Pathologic Nodal Disease in Clinically Node-Negative, Microinvasive or T1a Breast Cancers.
     Ann Surg Oncol. 2024;31:8821-8828.
     PubMed     Abstract available
     
     
     
255. LIMBERG JN, Jones T, Thomas SM, Ntowe KW, et al
     Omission of Axillary Lymph Node Dissection in Patients with Residual Nodal Disease After Neoadjuvant Chemotherapy.
     Ann Surg Oncol. 2024;31:8813-8820.
     PubMed     Abstract available
     
     
     November 2024
256. SAMPLE JW, Hoskin TL, Johnson JE, Mrdutt MM, et al
     ASO Visual Abstract: Early Compliance with Commission on Cancer Operative Standards for Breast Cancer Surgery.
     Ann Surg Oncol. 2024 Nov 26. doi: 10.1245/s10434-024-16583.
     PubMed    
     
     
     
257. HUSTON-PATERSON HH, Mora V, Karlan BY, Teshome M, et al
     Medicaid Coverage of NCCN- and ASCO/SSO-Guideline-Concordant BRCA Germline Testing for Patients with Breast Cancer: Opportunity to Embrace Rapid Advancements in Precision Medicine.
     Ann Surg Oncol. 2024 Nov 23. doi: 10.1245/s10434-024-16306.
     PubMed     Abstract available
     
     
     
258. PANG J, Ding N, Liu X, He X, et al
     Prognostic Value of the Baseline Systemic Immune-Inflammation Index in HER2-Positive Metastatic Breast Cancer: Exploratory Analysis of Two Prospective Trials.
     Ann Surg Oncol. 2024 Nov 20. doi: 10.1245/s10434-024-16454.
     PubMed     Abstract available
     
     
     
259. SO A, Yi M, Simons JM, Kuerer HM, et al
     ASO Visual Abstract: Significance of Residual Nodal Disease in Clinically Node-Negative Breast Cancer After Neoadjuvant Chemotherapy.
     Ann Surg Oncol. 2024 Nov 19. doi: 10.1245/s10434-024-16506.
     PubMed    
     
     
     
260. MUPPIDI N, Adesoye T, Yi M, Sun SX, et al
     ASO Visual Abstract: Clinical Outcomes for Early-Stage Node-Negative HER2-Positive Breast Cancer Patients Receiving Upfront Surgery or Neoadjuvant Systemic Therapy.
     Ann Surg Oncol. 2024 Nov 19. doi: 10.1245/s10434-024-16213.
     PubMed    
     
     
     
261. HU J, Deng X, Li L, Liu H, et al
     ASO Visual Abstract: The Predictive Factors of Combined Implant Application for Breast Cancer Patients Receiving Immediate Breast Reconstruction with a Pedicled Omental Flap.
     Ann Surg Oncol. 2024 Nov 16. doi: 10.1245/s10434-024-16500.
     PubMed    
     
     
     
262. SO A, Hunt KK
     ASO Author Reflections: De-escalating Axillary Surgery in Patients with Clinically Node-Negative Breast Cancer After Neoadjuvant Chemotherapy.
     Ann Surg Oncol. 2024 Nov 13. doi: 10.1245/s10434-024-16461.
     PubMed    
     
     
     
263. SAMPLE JW, Hoskin TL, Johnson JE, Mrdutt MM, et al
     Early Compliance with Commission on Cancer Operative Standards for Breast Cancer Surgery.
     Ann Surg Oncol. 2024 Nov 10. doi: 10.1245/s10434-024-16477.
     PubMed     Abstract available
     
     
     
264. VASIGH M, Mohamed A, Jacobs L, Lange J, et al
     ASO Visual Abstract: The Association Between Breast Cancer Predisposing Genetic Variants and Multifocal, Multicentric Breast Cancer.
     Ann Surg Oncol. 2024 Nov 5. doi: 10.1245/s10434-024-16404.
     PubMed    
     
     
     
265. MCCAFFREY RL, James AJ, Torres-Guzman RA, Addae JK, et al
     Incidence of High Risk and Malignant Pathological Findings in Transgender and Gender Diverse Individuals Undergoing Gender-Affirming Mastectomy.
     Ann Surg Oncol. 2024;31:8086-8092.
     PubMed     Abstract available
     
     
     
266. GOTTIPATI S, Goldbach M, Tchou J
     ASO Author Reflections: Rationale to Routinely Retest ER, PR and HER-2/neu Receptor Status in Residual Disease After Neoadjvuant Chemotherapy.
     Ann Surg Oncol. 2024;31:8108-8109.
     PubMed    
     
     
     
267. HO IW, Chichura A, Pederson HJ, Xavier BA, et al
     Current State of Evidence-Based Long-Term Monitoring Protocols for Breast Plastic Surgery Patients.
     Ann Surg Oncol. 2024;31:8372-8382.
     PubMed     Abstract available
     
     
     
268. HANEY V, Lee SM, Goldman J, Akiska YM, et al
     Evaluating the Effect of MarginProbe((R)) Use on Re-excisions After Partial Mastectomy: A Single-Institution Analysis.
     Ann Surg Oncol. 2024;31:8068-8075.
     PubMed     Abstract available
     
     
     
269. DEL CALVO H, Wu Y, Lin HY, Nassif EF, et al
     Margin Width and Local Recurrence in Patients with Phyllodes Tumors of the Breast.
     Ann Surg Oncol. 2024;31:8048-8056.
     PubMed     Abstract available
     
     
     
270. KIM M, Tadros AB, Boe LA, Vingan P, et al
     Breast-Conserving Therapy Versus Postmastectomy Breast Reconstruction: Propensity Score-Matched Analysis.
     Ann Surg Oncol. 2024;31:8030-8039.
     PubMed     Abstract available
     
     
     
271. AMAKIRI UO, Tadros AB, Kim M, Boe LA, et al
     ASO Author Reflections: Propensity Score-Matched Patient-Reported Outcomes After Breast-Conserving Therapy and Postmastectomy Breast Reconstruction.
     Ann Surg Oncol. 2024;31:8104-8105.
     PubMed    
     
     
     October 2024
272. MOORE AM, Caudle AS, Sun SX, Yi M, et al
     ASO Visual Abstract: Impact of Clipped Node as a Sentinel Lymph Node on Axillary Staging Following Neoadjuvant Chemotherapy in Clinically Node-Positive Breast Cancer.
     Ann Surg Oncol. 2024 Oct 23. doi: 10.1245/s10434-024-16397.
     PubMed    
     
     
     
273. SO A, Yi M, Simons JM, Kuerer HM, et al
     Significance of Residual Nodal Disease in Clinically Node-Negative Breast Cancer After Neoadjuvant Chemotherapy.
     Ann Surg Oncol. 2024 Oct 23. doi: 10.1245/s10434-024-16382.
     PubMed     Abstract available
     
     
     
274. BAYLEY EM, Liu HY, Bonetti MA, Egro FM, et al
     ChatGPT as Valuable Patient Education Resource in Breast Cancer Care.
     Ann Surg Oncol. 2024 Oct 23. doi: 10.1245/s10434-024-16369.
     PubMed    
     
     
     
275. CONNORS C, Valente SA, ElSherif A, Escobar P, et al
     Real-World Outcomes with the KEYNOTE-522 Regimen in Early-Stage Triple-Negative Breast Cancer.
     Ann Surg Oncol. 2024 Oct 22. doi: 10.1245/s10434-024-16390.
     PubMed     Abstract available
     
     
     
276. MOORE AM, Caudle AS, Sun SX, Yi M, et al
     Impact of Clipped Node as a Sentinel Lymph Node on Axillary Staging Following Neoadjuvant Chemotherapy in Clinically Node-Positive Breast Cancer.
     Ann Surg Oncol. 2024 Oct 17. doi: 10.1245/s10434-024-16341.
     PubMed     Abstract available
     
     
     
277. ESPARHAM A, Shoar S, Whittington J, Shafaee Z, et al
     ASO Author Reflections: Immediate Implant-Based Versus Autologous-Based Breast Reconstruction After Mastectomy in Patients with Breast Cancer.
     Ann Surg Oncol. 2024 Oct 12. doi: 10.1245/s10434-024-16374.
     PubMed    
     
     
     
278. KIM LS, Moore MS, Schneider E, Canner J, et al
     ASO Visual Abstract: National Patterns of Hospital Admission Versus Home Recovery Following Mastectomy for Breast Cancer.
     Ann Surg Oncol. 2024 Oct 2. doi: 10.1245/s10434-024-16259.
     PubMed    
     
     
     
279. KIM M, Matros E, Boe LA, Stern CS, et al
     Predicting Postoperative Satisfaction with Breasts: How Important is the Preoperative BREAST-Q Score?
     Ann Surg Oncol. 2024;31:6602-6610.
     PubMed     Abstract available
     
     
     
280. LORENTZEN EH, Chen YJ, Jin G, King TA, et al
     Potential Overtreatment of DCIS in Patients with Limited Life Expectancy.
     Ann Surg Oncol. 2024;31:6812-6819.
     PubMed     Abstract available
     
     
     
281. JONES VM, Nelson JA, Sevilimedu V, Le T, et al
     Impact of Mastectomy Flap Necrosis on Patient-Reported Quality-of-Life Measures After Nipple-Sparing Mastectomy: A Preliminary Analysis.
     Ann Surg Oncol. 2024;31:6795-6803.
     PubMed     Abstract available
     
     
     
282. DOMINICI LS, Laws A, Lagendijk M, Grossmith S, et al
     Correction: Patient-Reported Outcomes 10 Years After Breast-Conserving Surgery for Early-Stage Breast Cancer.
     Ann Surg Oncol. 2024 Oct 1. doi: 10.1245/s10434-024-16315.
     PubMed    
     
     
     
283. GASS J, Teshome M, Blair SL
     25nd Annual Meeting of the American Society of Breast Surgeons: Our Silver Jubilee.
     Ann Surg Oncol. 2024;31:7245-7246.
     PubMed    
     
     
     
284. JACKSON KM, Grumley JG
     ASO Author Reflections: Employment of Oncoplastic Breast Surgery for Management of Large, Multifocal, or Multicentric Breast Cancers: Another Tool in the Toolbox.
     Ann Surg Oncol. 2024;31:7594-7595.
     PubMed    
     
     
     
285. MILLEN JC, Grumley JG
     ASO Author Reflections: Cost Comparison of Extreme Oncoplastic Breast-Conserving Surgery and Mastectomy with Reconstruction.
     Ann Surg Oncol. 2024;31:7471.
     PubMed    
     
     
     
286. ELMORE LR, Bayley EM, Clark BZ, McAuliffe PF, et al
     Is the Number or Proximity of Margins Less than 2 mm Associated with an Increased Mastectomy Rate in Patients Attempting Breast Conservation Therapy for Ductal Carcinoma In Situ?
     Ann Surg Oncol. 2024;31:7609-7618.
     PubMed     Abstract available
     
     
     
287. HUA T, Wright GP, Thompson JL
     ASO Author Reflections: The Utility of Clinical Breast Examinations in a High-Risk Patient Population.
     Ann Surg Oncol. 2024;31:7532-7533.
     PubMed    
     
     
     
288. JACKSON KM, Millen JC, Handy N, Orozco JIJ, et al
     Breast Conservation Project: Clinical Outcomes of Extreme Oncoplastic Breast-Conserving Therapy Versus Mastectomy for Large and Multiple Lesions.
     Ann Surg Oncol. 2024;31:7582-7593.
     PubMed     Abstract available
     
     
     
289. AUBREY JM, Levine A, Movassaghi A, Liefeld HR, et al
     2021 CMS Evaluation and Management Guideline Changes Reduce Note Length in Outpatient Breast Surgery Documentation.
     Ann Surg Oncol. 2024;31:7535-7537.
     PubMed    
     
     
     
290. WEISS A, Mitchell M, O'Sullivan CC, Boughey JC, et al
     ASO Author Reflections: Extreme Early Adoption-The Omission of Axillary Lymph Node Dissection is Being Adopted into Practice Before Clinical Trial Data are Available: Where Might this Lead?
     Ann Surg Oncol. 2024;31:7372-7374.
     PubMed    
     
     
     
291. CLELLAND EN, Mukhtar RA
     ASO Author Reflections: Detecting Local Recurrence After Primary Treatment for Invasive Lobular Carcinoma of the Breast.
     Ann Surg Oncol. 2024;31:7323-7324.
     PubMed    
     
     
     
292. GAO TP, HoSang KM, Bleicher RJ, Kuo LE, et al
     Evolving Economics: The Erosion of Medicare Reimbursement in Breast Surgery (2003-2023).
     Ann Surg Oncol. 2024;31:7303-7311.
     PubMed     Abstract available
     
     
     
293. VEMURU S, Helmkamp L, Adams M, Colborn K, et al
     Longitudinal Trends in Patient-Reported Outcomes in the First Year After Lumpectomy Versus Mastectomy.
     Ann Surg Oncol. 2024;31:7597-7606.
     PubMed     Abstract available
     
     
     
294. DALTON EC, Williams AD
     ASO Author Reflections: Put the Scalpel Down-Axillary Surgery is not Indicated for Patients >/= 70 Years Undergoing Mastectomy for DCIS.
     Ann Surg Oncol. 2024;31:7508-7509.
     PubMed    
     
     
     
295. CARDARELLI CL, Dalton EC, Chang C, Williams AD, et al
     Should Palpable Nodes Be Exclusionary in Patients Who Are Otherwise Candidates for ACOSOG Z0011-Type Trials?
     Ann Surg Oncol. 2024;31:7445-7458.
     PubMed     Abstract available
     
     
     
296. HOSSINO D, Silverstein MJ, Savalia N, Jayich M, et al
     Extreme Oncoplasty: Oncologically Safe When Compared with Mastectomy.
     Ann Surg Oncol. 2024;31:7284-7288.
     PubMed     Abstract available
     
     
     
297. MILLEN JC, Sibia U, Jackson K, Stern SL, et al
     Comparing Costs: Does Extreme Oncoplastic Breast-Conserving Surgery Confer a Cost Benefit When Compared with Mastectomy and Reconstruction?
     Ann Surg Oncol. 2024;31:7463-7470.
     PubMed     Abstract available
     
     
     
298. PILTIN MA, Norwood P, Ladores V, Mukhtar RA, et al
     Internal Mammary Lymphadenopathy Does Not Impact Oncologic Outcomes in Patients Treated with Neoadjuvant Chemotherapy: Results from the I-SPY2 Clinical Trial.
     Ann Surg Oncol. 2024;31:7420-7428.
     PubMed     Abstract available
     
     
     
299. DALTON EC, Chang C, Cardarelli C, Bleicher RJ, et al
     Nodal Surgery for Patients >/= 70 Undergoing Mastectomy for DCIS? Choose Wisely.
     Ann Surg Oncol. 2024;31:7498-7507.
     PubMed     Abstract available
     
     
     
300. WEISS A, Colugnati F, Mitchell M, Li Y, et al
     Contemporary Axillary Surgical Management in Patients with Pathologically Node Positive Disease After Neoadjuvant Chemotherapy: A Survey of Members of the American Society of Breast Surgeons.
     Ann Surg Oncol. 2024;31:7362-7371.
     PubMed     Abstract available
     
     
     
301. JAKUB JW, Boughey JC, Hieken TJ, Piltin M, et al
     Lymphedema Rates Following Axillary Lymph Node Dissection With and Without Immediate Lymphatic Reconstruction: A Prospective Trial.
     Ann Surg Oncol. 2024;31:7349-7359.
     PubMed     Abstract available
     
     
     
302. CLELLAND EN, Quirarte A, Rothschild HT, Kaur M, et al
     Surveillance Strategies After Primary Treatment for Patients with Invasive Lobular Carcinoma of the Breast: Method of Local Recurrence Detection After Breast-Conserving Surgery.
     Ann Surg Oncol. 2024;31:7315-7322.
     PubMed     Abstract available
     
     
     
303. FALADE I, Mukhtar RA
     ASO Author Reflections: The Oncologic Safety of Immediate Oncoplastic Approaches in Invasive Lobular Carcinoma.
     Ann Surg Oncol. 2024;31:7418-7419.
     PubMed    
     
     
     
304. FALADE I, Switalla K, Quirarte A, Baxter M, et al
     Oncologic Safety of Immediate Oncoplastic Surgery Compared with Standard Breast-Conserving Surgery for Patients with Invasive Lobular Carcinoma.
     Ann Surg Oncol. 2024;31:7409-7417.
     PubMed     Abstract available
     
     
     September 2024
305. SHIM V, Karlea A, Habel L
     ASO Author Reflections: Mainstream Genetic Testing Makes It Feasible for a Large Integrated System to Expand the Testing Eligibility in Breast Cancer.
     Ann Surg Oncol. 2024 Sep 28. doi: 10.1245/s10434-024-16311.
     PubMed    
     
     
     
306. VASIGH M, Mohamed A, Jacobs L, Lange J, et al
     The Association Between Breast Cancer Predisposing Genetic Variants and Multifocal, Multicentric Breast Cancer.
     Ann Surg Oncol. 2024 Sep 27. doi: 10.1245/s10434-024-16243.
     PubMed     Abstract available
     
     
     
307. KIM LS, Moore MS, Schneider E, Canner J, et al
     National Patterns of Hospital Admission Versus Home Recovery Following Mastectomy for Breast Cancer.
     Ann Surg Oncol. 2024 Sep 25. doi: 10.1245/s10434-024-16107.
     PubMed     Abstract available
     
     
     
308. DOMINICI LS, Laws A, Lagendijk M, Grossmith S, et al
     ASO Visual Abstract: Patient-Reported Outcomes 10 Years After Breast-Conserving Surgery for Early-Stage Breast Cancer.
     Ann Surg Oncol. 2024 Sep 25. doi: 10.1245/s10434-024-16070.
     PubMed    
     
     
     
309. MYERS SP, Aviki E, Sevilimedu V, Thom B, et al
     ASO Visual Abstract: Financial Toxicity Among Women with Breast Cancer Varies by Age and Race.
     Ann Surg Oncol. 2024 Sep 25. doi: 10.1245/s10434-024-16091.
     PubMed    
     
     
     
310. SAUCKE MC, Jacobson N, McKinney G, Neuman HB, et al
     Role of the Surgeon in De-Escalating Emotion During a Breast Cancer Surgery Consultation: A Qualitative Study of Patients' Experiences in Alliance A231701CD.
     Ann Surg Oncol. 2024 Sep 25. doi: 10.1245/s10434-024-16156.
     PubMed     Abstract available
     
     
     
311. PITSINIS V, Kanitkar R, Vinci A, Choong WL, et al
     ASO Author Reflections: ICG Fluorescent-Guided Surgery for Sentinel Lymph Node Biopsy Used as a Single Tracer Shown Sensitivity, Safety, and Efficacy in Early Breast Cancer Surgery.
     Ann Surg Oncol. 2024 Sep 23. doi: 10.1245/s10434-024-16266.
     PubMed    
     
     
     
312. FREEMAN JQ, Huo D, Howard FM
     ASO Author Reflections: Breast-Conserving Surgery After Neoadjuvant Systemic Therapy for Early-Stage Breast Cancer: Quantitative Biomarkers and Disparities in the Precision-Medicine Era.
     Ann Surg Oncol. 2024 Sep 23. doi: 10.1245/s10434-024-16265.
     PubMed     Abstract available
     
     
     
313. RECORD SM, Thomas SM, Dalton J, van den Bruele AB, et al
     ASO Visual Abstract: Triple-Negative Breast Cancer in Older Patients: Does SLNB Guide Therapy?
     Ann Surg Oncol. 2024 Sep 21. doi: 10.1245/s10434-024-16249.
     PubMed    
     
     
     
314. FU MR, Liu B, Qiu JM, Sun Y, et al
     ASO Visual Abstract: The Effects of Daily-Living Risks on Breast Cancer-Related Lymphedema.
     Ann Surg Oncol. 2024 Sep 19. doi: 10.1245/s10434-024-16231.
     PubMed    
     
     
     
315. SHIM V, Karlea A, Brenman LM, Gul J, et al
     Mainstream Germline Genetic Testing with Expanded Eligibility for Early Breast Cancer Patients in a Large Integrated Health System.
     Ann Surg Oncol. 2024 Sep 18. doi: 10.1245/s10434-024-16223.
     PubMed     Abstract available
     
     
     
316. PARRISH KM, Thomas SM, Cartwright SB, van den Bruele AB, et al
     ASO Visual Abstract: Rates of Pathologic Complete Response and Overall Survival in Patients with Inflammatory Breast Cancer-A National Cancer Database Study.
     Ann Surg Oncol. 2024 Sep 18. doi: 10.1245/s10434-024-16206.
     PubMed    
     
     
     
317. AN SJ, Thai CHNC, Ismail S, Agala CB, et al
     ASO Visual Abstract: Nodal Response and Survival After Neoadjuvant Endocrine Therapy in Hormone Receptor-Positive Breast Cancer: 20-Year Experience from a Single Institution.
     Ann Surg Oncol. 2024 Sep 16. doi: 10.1245/s10434-024-16210.
     PubMed    
     
     
     
318. FINE RE, Gilmore RC, Tomkovich KR, Dietz JR, et al
     Cryoablation Without Excision for Early-Stage Breast Cancer: ICE3 Trial 5-Year Follow-Up on Ipsilateral Breast Tumor Recurrence.
     Ann Surg Oncol. 2024 Sep 16. doi: 10.1245/s10434-024-16181.
     PubMed     Abstract available
     
     
     
319. PITSINIS V, Kanitkar R, Vinci A, Choong WL, et al
     Results of a Prospective Randomized Multicenter Study Comparing Indocyanine Green (ICG) Fluorescence Combined with a Standard Tracer Versus ICG Alone for Sentinel Lymph Node Biopsy in Early Breast Cancer: The INFLUENCE Trial.
     Ann Surg Oncol. 2024 Sep 12. doi: 10.1245/s10434-024-16176.
     PubMed     Abstract available
     
     
     
320. DALTON JC, Record SM, Plichta JK
     ASO Author Reflections: Investigating the Role of Sentinel Lymph Node Biopsy in Older Patients with Triple-Negative Breast Cancer.
     Ann Surg Oncol. 2024 Sep 12. doi: 10.1245/s10434-024-16236.
     PubMed    
     
     
     
321. FREEMAN JQ, Shubeck SP, Chen N, Yarlagadda SR, et al
     Quantitative Biomarkers, Genomic Assays, and Demographics Associated with Breast-Conserving Surgery Following Neoadjuvant Therapy in Early-Stage, Hormone Receptor-Positive, HER-Negative Breast Cancer.
     Ann Surg Oncol. 2024 Sep 9. doi: 10.1245/s10434-024-16160.
     PubMed     Abstract available
     
     
     
322. MUPPIDI N, Adesoye T, Hunt KK, Teshome M, et al
     ASO Author Reflections: Evolving Multidisciplinary Decision Making for Early-Stage, HER2-Positive Breast Cancer.
     Ann Surg Oncol. 2024 Sep 9. doi: 10.1245/s10434-024-16190.
     PubMed    
     
     
     
323. PARRISH K, Chiba A
     ASO Author Reflections: Not All pCRs are Created Equal, the Challenge of Inflammatory Breast Cancer.
     Ann Surg Oncol. 2024 Sep 7. doi: 10.1245/s10434-024-16129.
     PubMed    
     
     
     
324. SHAH C, Whitworth P, Vicini FA, Narod S, et al
     ASO Visual Abstract: The Clinical Utility of a 7-Gene Biosignature on Radiation Therapy Decision Making in Patients with Ductal Carcinoma In Situ Following Breast-Conserving Surgery: An Updated Analysis of the DCISionRT((R)) PREDICT Study.
     Ann Surg Oncol. 2024;31:5959-5960.
     PubMed    
     
     
     
325. SHAH C, Whitworth P, Vicini FA, Narod S, et al
     The Clinical Utility of a 7-Gene Biosignature on Radiation Therapy Decision Making in Patients with Ductal Carcinoma In Situ Following Breast-Conserving Surgery: An Updated Analysis of the DCISionRT((R)) PREDICT Study.
     Ann Surg Oncol. 2024;31:5919-5928.
     PubMed     Abstract available
     
     
     
326. RAHURKAR S, Jonnalagadda P, Stover D, Andersen B, et al
     Identifying and Treating Those at Risk: Disparities in Rapid Relapse Among TNBC Patients in the National Cancer Database.
     Ann Surg Oncol. 2024;31:5896-5910.
     PubMed     Abstract available
     
     
     
327. PARK KU, Padamsee TJ, Birken SA, Lee S, et al
     Factors Influencing Implementation of the Commission on Cancer's Breast Synoptic Operative Report (Alliance A20_Pilot9).
     Ann Surg Oncol. 2024;31:5888-5895.
     PubMed     Abstract available
     
     
     
328. SETO Y, Ishitobi M, Shien T, Oshiro C, et al
     ASO Visual Abstract: Patient Preference for Surgical Methods for Ipsilateral Breast Tumor Recurrence.
     Ann Surg Oncol. 2024;31:5957-5958.
     PubMed    
     
     
     August 2024
329. CORTINA CS, Purdy A, Brazauskas R, Stachowiak SM, et al
     ASO Visual Abstract: The Impact of a Breast Cancer Risk Assessment on the Decision for Gender-Affirming Chest Masculinization Surgery in Transgender and Gender-Diverse Individuals-A Pilot Single-Arm Educational Intervention Trial.
     Ann Surg Oncol. 2024 Aug 30. doi: 10.1245/s10434-024-15905.
     PubMed    
     
     
     
330. FERRUCCI M, Passeri D, Milardi F, Francavilla A, et al
     ASO Visual Abstract: Surgery Plays a Leading Role in Breast Cancer Treatment for Patients Aged >/= 90 Years: A Large Retrospective Cohort Study.
     Ann Surg Oncol. 2024 Aug 29. doi: 10.1245/s10434-024-16086.
     PubMed    
     
     
     
331. RECORD SM, Thomas SM, Dalton J, van den Bruele AB, et al
     Triple-Negative Breast Cancer in Older Patients: Does SLNB Guide Therapy?
     Ann Surg Oncol. 2024 Aug 28. doi: 10.1245/s10434-024-16106.
     PubMed     Abstract available
     
     
     
332. MUPPIDI N, Adesoye T, Yi M, Sun SX, et al
     Clinical Outcomes in Patients with Early Stage Node-Negative HER2-Positive Breast Cancer Receiving Upfront Surgery or Neoadjuvant Systemic Therapy.
     Ann Surg Oncol. 2024 Aug 27. doi: 10.1245/s10434-024-16087.
     PubMed     Abstract available
     
     
     
333. FU MR, Liu B, Qiu JM, Sun Y, et al
     ASO Author Reflections: Infection and Skin Trauma Incrementally Increase the Risk of Breast Cancer-Related Lymphedema.
     Ann Surg Oncol. 2024 Aug 25. doi: 10.1245/s10434-024-16078.
     PubMed    
     
     
     
334. MYERS SP, Aviki E, Sevilimedu V, Thom B, et al
     ASO Author Reflections: Young Adults and Racial Minorities May Be at High Risk for Financial Toxicity After Breast Cancer Treatment.
     Ann Surg Oncol. 2024 Aug 22. doi: 10.1245/s10434-024-16050.
     PubMed    
     
     
     
335. LIMBERG JN, Thomas SM, Dalton JC, Ntowe KW, et al
     ASO Visual Abstract: Trajectory of Subsequent Breast Cancer Diagnoses in a Diverse Patient Cohort with Breast Atypia.
     Ann Surg Oncol. 2024 Aug 19. doi: 10.1245/s10434-024-15963.
     PubMed    
     
     
     
336. TCHOU J, Gottipati S, Goldbach M, Baxter M, et al
     ASO Visual Abstract: Change in Biomarker Profile After Neoadjuvant Chemotherapy is Prognostic and is Common in Patients with HER2+ Breast Cancer.
     Ann Surg Oncol. 2024 Aug 19. doi: 10.1245/s10434-024-16090.
     PubMed    
     
     
     
337. PARRISH KM, Thomas SM, Cartwright SB, van den Bruele AB, et al
     Rates of Pathologic Complete Response and Overall Survival in Patients with Inflammatory Breast Cancer: A National Cancer Database Study.
     Ann Surg Oncol. 2024 Aug 19. doi: 10.1245/s10434-024-16026.
     PubMed     Abstract available
     
     
     
338. AN SJ, Thai CHNC, Ismail S, Agala CB, et al
     Nodal Response and Survival After Neoadjuvant Endocrine Therapy in Hormone Receptor-Positive Breast Cancer: 20-Year Experience from a Single Institution.
     Ann Surg Oncol. 2024 Aug 17. doi: 10.1245/s10434-024-16059.
     PubMed     Abstract available
     
     
     
339. MACCALLUM C, Elder K, Nickson C, Ruecker K, et al
     ASO Visual Abstract: Contrast-Enhanced Mammography in Local Staging of Screen-Detected Breast Cancer.
     Ann Surg Oncol. 2024 Aug 17. doi: 10.1245/s10434-024-15996.
     PubMed    
     
     
     
340. HERNANDEZ AE, Borowsky PA, Lubarsky M, Carroll C, et al
     ASO Visual Abstract: Associations Between Perceived Discrimination, Screening Mammography, and Breast Cancer Stage at Diagnosis: A Prospective Cohort Analysis.
     Ann Surg Oncol. 2024 Aug 16. doi: 10.1245/s10434-024-15990.
     PubMed    
     
     
     
341. SWITALLA KM, Boughey JC, Dimitroff K, Yau C, et al
     ASO Visual Abstract: Clipping the Positive Lymph Node in Patients with Clinically Node-Positive Breast Cancer Treated with Neoadjuvant Chemotherapy: Impact on Axillary Surgery in the ISPY-2 Clinical Trial.
     Ann Surg Oncol. 2024 Aug 13. doi: 10.1245/s10434-024-15965.
     PubMed    
     
     
     
342. CHENG O, Fiser C, Paysour J, Aluwalia R, et al
     Defining the Need for Services for Patients at High Risk of Breast Cancer at a Safety-Net Hospital: An Approach to Narrowing the Disparities Gap.
     Ann Surg Oncol. 2024 Aug 13. doi: 10.1245/s10434-024-15789.
     PubMed     Abstract available
     
     
     
343. KHORFAN R, Vora HP, Namm JP, Solomon NL, et al
     Expanded Indications for Neoadjuvant Endocrine Therapy in Early-Stage Breast Cancer During the COVID-19 Pandemic.
     Ann Surg Oncol. 2024 Aug 12. doi: 10.1245/s10434-024-15787.
     PubMed     Abstract available
     
     
     
344. GLENCER AC, Wanis KN, Brown S, Lucci A, et al
     ASO Visual Abstract: Self-Reported Management of Inflammatory Breast Cancer Among the American Society of Breast Surgeons Membership-Consensus and Opportunities.
     Ann Surg Oncol. 2024 Aug 10. doi: 10.1245/s10434-024-15910.
     PubMed    
     
     
     
345. LOHANI KR, Hoskin TL, Yasir S, Olson CA, et al
     Clipped Axillary Node as a Potential Surrogate for Overall Axillary Nodal Status in Inflammatory Breast Cancer Patients after Neoadjuvant Chemotherapy.
     Ann Surg Oncol. 2024 Aug 9. doi: 10.1245/s10434-024-15796.
     PubMed     Abstract available
     
     
     
346. TCHOU J, Gottipati S, Goldbach M, Baxter M, et al
     Change in Biomarker Profile After Neoadjuvant Chemotherapy is Prognostic and Common Among Patients with HER2+ Breast Cancer.
     Ann Surg Oncol. 2024 Aug 8. doi: 10.1245/s10434-024-15889.
     PubMed     Abstract available
     
     
     
347. DI LENA E, Iny E, Wong SM, Bassel M, et al
     ASO Visual Abstract: Impact of Margin Status on Local Recurrence in Patients with Breast Cancer Undergoing Breast-Conserving Surgery After Neoadjuvant Chemotherapy: A Retrospective Multi-Institutional Cohort Study.
     Ann Surg Oncol. 2024 Aug 8. doi: 10.1245/s10434-024-15961.
     PubMed    
     
     
     
348. MATTAR A, Antonini M, Amorim A, Mateus EF, et al
     ASO Visual Abstract: PROMRIINE (PRe-operatory Magnetic Resonance Imaging is INEffective) Study: A Systematic Review and Meta-analysis of the Impact of Magnetic Resonance Imaging on Surgical Decisions and Clinical Outcomes in Women with Breast Cancer.
     Ann Surg Oncol. 2024 Aug 6. doi: 10.1245/s10434-024-15971.
     PubMed    
     
     
     
349. WANIS KN, Goetz L, So A, Glencer AC, et al
     ASO Visual Abstract: The Prevalence of Sentinel Lymph Node Positivity and Implications for the Utility of Frozen Section Diagnosis Following Neoadjuvant Systemic Therapy in Patients with Clinically Node-Negative HER2-Positive or Triple-Negative Breast
     Ann Surg Oncol. 2024 Aug 6. doi: 10.1245/s10434-024-15913.
     PubMed    
     
     
     
350. HERNANDEZ AE, Borowsky PA, Lubarsky M, Carroll C, et al
     Correction: Associations Between Perceived Discrimination, Screening Mammography, and Breast Cancer Stage at Diagnosis: A Prospective Cohort Analysis.
     Ann Surg Oncol. 2024 Aug 5. doi: 10.1245/s10434-024-16009.
     PubMed    
     
     
     
351. FERRUCCI M, Passeri D, Milardi F, Francavilla A, et al
     Surgery Plays a Leading Role in Breast Cancer Treatment for Patients Aged >/=90 Years: A Large Retrospective Cohort Study.
     Ann Surg Oncol. 2024 Aug 4. doi: 10.1245/s10434-024-15790.
     PubMed     Abstract available
     
     
     
352. KHORFAN R, Vora HP, Namm JP, Solomon NL, et al
     ASO Visual Abstract: Expanded Indications for Neoadjuvant Endocrine Therapy in Early Stage Breast Cancer During the COVID-19 Pandemic.
     Ann Surg Oncol. 2024 Aug 4. doi: 10.1245/s10434-024-15921.
     PubMed    
     
     
     
353. DALTON JC, Crowell KA, Ntowe KW, van den Bruele AB, et al
     ASO Visual Abstract: Utility of Axillary Staging in Older Patients with HER2-Positive Breast Cancer.
     Ann Surg Oncol. 2024 Aug 2. doi: 10.1245/s10434-024-15972.
     PubMed    
     
     
     
354. FALADE I, Switalla K, Quirarte A, Baxter M, et al
     ASO Visual Abstract: Oncologic Safety of Immediate Oncoplastic Surgery Compared to Standard Breast Conserving Surgery for Patients with Invasive Lobular Carcinoma.
     Ann Surg Oncol. 2024;31:5004-5005.
     PubMed    
     
     
     
355. DALY AE, Anderman KJ, Smith BL
     ASO Author Reflections: Positive Nipple Margins in Nipple-Sparing Mastectomy: Management of Nipples Containing Cancer or Atypia.
     Ann Surg Oncol. 2024;31:5211-5212.
     PubMed    
     
     
     
356. SHANNO JN, Daly AE, Anderman KJ, Santa Cruz HS, et al
     ASO Visual Abstract: Positive Nipple Margins in Nipple Sparing Mastectomy-Management of Nipples Containing Cancer or Atypia.
     Ann Surg Oncol. 2024;31:5230.
     PubMed    
     
     
     
357. HAMID SA, Bakkila B, Schultz KS, Grimshaw AA, et al
     ASO Visual Abstract: "Peace of Mind" After Mastectomy: A Scoping Review.
     Ann Surg Oncol. 2024;31:5213-5214.
     PubMed    
     
     
     
358. WANG CS, Al-Nowaylati AR, Matusko N, Momoh AO, et al
     ASO Visual Abstract: Simultaneous Co-surgeon Deep Inferior Epigastric Perforator (DIEP) Flap Breast Reconstructions-Feasibility and Clinical Outcomes.
     Ann Surg Oncol. 2024;31:5419-5420.
     PubMed    
     
     
     
359. BEST CS, Kung TA
     ASO Author Reflections: Improving Patient Access to Autologous Breast Reconstruction.
     Ann Surg Oncol. 2024;31:5417-5418.
     PubMed    
     
     
     
360. HAMID SA, Bakkila B, Schultz KS, Grimshaw AA, et al
     "Peace of Mind" After Mastectomy: A Scoping Review.
     Ann Surg Oncol. 2024;31:5168-5179.
     PubMed     Abstract available
     
     
     
361. SHANNO JN, Daly AE, Anderman KJ, Santa Cruz HS, et al
     Positive Nipple Margins in Nipple-Sparing Mastectomy: Management of Nipples Containing Cancer or Atypia.
     Ann Surg Oncol. 2024;31:5148-5156.
     PubMed     Abstract available
     
     
     
362. WANG CS, Al-Nowaylati AR, Matusko N, Momoh AO, et al
     Simultaneous Co-surgeon Deep Inferior Epigastric Perforator (DIEP) Flap Breast Reconstructions: Feasibility and Clinical Outcomes.
     Ann Surg Oncol. 2024;31:5409-5416.
     PubMed     Abstract available
     
     
     
363. FU MR, Liu B, Qiu JM, Sun Y, et al
     The Effects of Daily-Living Risks on Breast Cancer-Related Lymphedema.
     Ann Surg Oncol. 2024 Aug 1. doi: 10.1245/s10434-024-15946.
     PubMed     Abstract available
     
     
     
364. NTOWE KW, Thomas SM, Dalton JC, Olunuga E, et al
     ASO Visual Abstract: Demographics and Clinical Decision Making in Patients with Germline Moderate Penetrance Non-BRCA Mutations in Breast Cancer Related Genes.
     Ann Surg Oncol. 2024 Aug 1. doi: 10.1245/s10434-024-15922.
     PubMed    
     
     
     
365. MOORE AM, Caudle AS, Sun SX, Yi M, et al
     ASO Visual Abstract: Residual Nodal Burden After Neoadjuvant Chemotherapy in cN1 Breast Cancer Patients with Positive Nodes on Targeted Axillary Dissection.
     Ann Surg Oncol. 2024 Aug 1. doi: 10.1245/s10434-024-15966.
     PubMed    
     
     
     July 2024
366. MACCALLUM C, Elder K, Nickson C, Ruecker K, et al
     ASO Author Reflections: Contrast-Enhanced Mammography in Local Staging of Screen-Detected Breast Cancer.
     Ann Surg Oncol. 2024 Jul 31. doi: 10.1245/s10434-024-15953.
     PubMed    
     
     
     
367. GAO T, HoSang K, Bleicher R, Kuo L, et al
     ASO Author Reflections: The Looming Challenge of Declining Reimbursements in Breast Cancer Care.
     Ann Surg Oncol. 2024 Jul 31. doi: 10.1245/s10434-024-15838.
     PubMed    
     
     
     
368. DALTON JC, Plichta JK
     ASO Author Reflections: Personalized Surgical Considerations in Older Women with HER2-Positive Breast Cancer.
     Ann Surg Oncol. 2024 Jul 31. doi: 10.1245/s10434-024-15930.
     PubMed    
     
     
     
369. SHAH C, Boyages J, Koelmeyer L, Chen SL, et al
     ASO Visual Abstract: Timing of Breast Cancer-Related Lymphedema Development Over 3 Years: Observations from a Large, Prospective Randomized Screening Trial Comparing Bioimpedance Spectroscopy (BIS) Versus Tape Measure.
     Ann Surg Oncol. 2024 Jul 31. doi: 10.1245/s10434-024-15906.
     PubMed    
     
     
     
370. PRATT CG, Whitrock JN, Carter MM, Long SA, et al
     ASO Visual Abstract: Implementation of Choosing Wisely(c) Recommendations for Lymph Node Surgery in Male Breast Cancer.
     Ann Surg Oncol. 2024 Jul 31. doi: 10.1245/s10434-024-15924.
     PubMed    
     
     
     
371. MYERS SP, Aviki E, Sevilimedu V, Thom B, et al
     Financial Toxicity Among Women with Breast Cancer Varies by Age and Race.
     Ann Surg Oncol. 2024 Jul 29. doi: 10.1245/s10434-024-15895.
     PubMed     Abstract available
     
     
     
372. HU J, Lu L
     ASO Author Reflections: Significance of Predicting Omental Insufficiency in Breast Cancer Patients Receiving Immediate Breast Reconstruction with Pedicled Omental Flap After Mastectomy.
     Ann Surg Oncol. 2024 Jul 29. doi: 10.1245/s10434-024-15958.
     PubMed    
     
     
     
373. LOHANI KR, Hoskin TL, Yasir S, Olson CA, et al
     ASO Visual Abstract: Clipped Axillary Node as a Potential Surrogate for Overall Axillary Nodal Status in Patients with Inflammatory Breast Cancer After Neoadjuvant Chemotherapy.
     Ann Surg Oncol. 2024 Jul 27. doi: 10.1245/s10434-024-15919.
     PubMed    
     
     
     
374. BELLINI A, Keegan THM, Li Q, Maguire FB, et al
     ASO Visual Abstract: Disparities in the Occurrence of Long-Term Effects of Bone Marrow Suppression after Treatment in Adolescent Young Adult Breast Cancer Survivors.
     Ann Surg Oncol. 2024 Jul 27. doi: 10.1245/s10434-024-15912.
     PubMed    
     
     
     
375. MATTAR A, Antonini M, Amorim A, Mateus EF, et al
     PROMRIINE (PRe-operatory Magnetic Resonance Imaging is INEffective) Study: A Systematic Review and Meta-analysis of the Impact of Magnetic Resonance Imaging on Surgical Decisions and Clinical Outcomes in Women with Breast Cancer.
     Ann Surg Oncol. 2024 Jul 27. doi: 10.1245/s10434-024-15833.
     PubMed     Abstract available
     
     
     
376. CHENG O, Postlewait LM
     ASO Author Reflections: Defining the Need for Services for Patients at High Risk of Breast Cancer at a Safety-Net Hospital: An Approach to Narrowing the Disparities Gap.
     Ann Surg Oncol. 2024 Jul 27. doi: 10.1245/s10434-024-15940.
     PubMed    
     
     
     
377. HUA T, Mendoza S, McCririe-Balcom M, Kelley J, et al
     ASO Visual Abstract: Routine Clinical Breast Examination is a Low-Yield Practice Among Women at High Risk of Breast Cancer.
     Ann Surg Oncol. 2024 Jul 27. doi: 10.1245/s10434-024-15914.
     PubMed    
     
     
     
378. MATTAR A
     ASO Author Reflection: Reevaluating the Role of Preoperative MRI in Breast Cancer Surgery: Lessons Learned and Future Directions.
     Ann Surg Oncol. 2024 Jul 27. doi: 10.1245/s10434-024-15925.
     PubMed    
     
     
     
379. LOHANI KR, Hoskin TL, Yasir S, Olson CA, et al
     ASO Author Reflections: Time to Explore Minimally Invasive Axillary Nodal Staging After Neo-Adjuvant Chemotherapy in Inflammatory Breast Cancer.
     Ann Surg Oncol. 2024 Jul 27. doi: 10.1245/s10434-024-15856.
     PubMed     Abstract available
     
     
     
380. DOLL A, Lipsyc-Sharf M, Sim MS, Baker JL, et al
     ASO Visual Abstract: Outcome of Patients with Pregnancy-Associated Breast Cancer Who Have Subsequent Pregnancies.
     Ann Surg Oncol. 2024 Jul 27. doi: 10.1245/s10434-024-15918.
     PubMed    
     
     
     
381. HERNANDEZ AE, Borowsky PA, Lubarsky M, Carroll C, et al
     Associations Between Perceived Discrimination, Screening Mammography, and Breast Cancer Stage at Diagnosis: A Prospective Cohort Analysis.
     Ann Surg Oncol. 2024 Jul 26. doi: 10.1245/s10434-024-15757.
     PubMed     Abstract available
     
     
     
382. CORTINA CS
     ASO Author Reflections: A Breast Cancer Risk Assessment and the Decision for Gender-Affirming Chest Masculinization Surgery or Oncologic Risk-Reducing Mastectomies in Transgender and Gender-Diverse Individuals.
     Ann Surg Oncol. 2024 Jul 26. doi: 10.1245/s10434-024-15801.
     PubMed    
     
     
     
383. FERRUCCI M, Passeri D, Milardi F, Montagna G, et al
     ASO Author Reflections: Breast Cancer in Patients Aged >/= 90 Years: Surgery or No Surgery-This Is the Question.
     Ann Surg Oncol. 2024 Jul 26. doi: 10.1245/s10434-024-15885.
     PubMed    
     
     
     
384. WANIS KN, Goetz L, So A, Glencer AC, et al
     The Prevalence of Sentinel Lymph Node Positivity and Implications for the Utility of Frozen Section Diagnosis Following Neoadjuvant Systemic Therapy in Patients with Clinically Node-Negative HER2-Positive or Triple-Negative Breast Cancer.
     Ann Surg Oncol. 2024 Jul 24. doi: 10.1245/s10434-024-15712.
     PubMed     Abstract available
     
     
     
385. MACCALLUM C, Elder K, Nickson C, Ruecker K, et al
     Contrast-Enhanced Mammography in Local Staging of Screen-Detected Breast Cancer.
     Ann Surg Oncol. 2024 Jul 24. doi: 10.1245/s10434-024-15848.
     PubMed     Abstract available
     
     
     
386. DOMINICI LS, Laws A, Lagendijk M, Grossmith S, et al
     Patient-Reported Outcomes 10 Years After Breast-Conserving Surgery for Early-Stage Breast Cancer.
     Ann Surg Oncol. 2024 Jul 24. doi: 10.1245/s10434-024-15876.
     PubMed     Abstract available
     
     
     
387. SWITALLA KM, Boughey JC, Mukhtar RA
     ASO Author Reflections: Evolving Paradigms in Axillary Management for Breast Cancer: Insights from the ISPY-2 Neoadjuvant Chemotherapy Trial.
     Ann Surg Oncol. 2024 Jul 24. doi: 10.1245/s10434-024-15873.
     PubMed    
     
     
     
388. HU J, Deng X, Li L, Liu H, et al
     The Predictive Factors of Combined Implant Application for Breast Cancer Patients Receiving Immediate Breast Reconstruction with a Pedicled Omental Flap.
     Ann Surg Oncol. 2024 Jul 24. doi: 10.1245/s10434-024-15882.
     PubMed     Abstract available
     
     
     
389. MOORE AM, Caudle AS, Sun SX, Yi M, et al
     Residual Nodal Burden After Neoadjuvant Chemotherapy in cN1 Breast Cancer Patients with Positive Nodes at Targeted Axillary Dissection.
     Ann Surg Oncol. 2024 Jul 23. doi: 10.1245/s10434-024-15797.
     PubMed     Abstract available
     
     
     
390. LEE EG, Lee DE, Jung SY, Han JH, et al
     Correction: ASO Author Reflections: Assessing the Efficacy of Multimodal Sentinel Lymph Node Mapping in Breast Cancer Patients After Neoadjuvant Chemotherapy.
     Ann Surg Oncol. 2024 Jul 23. doi: 10.1245/s10434-024-15901.
     PubMed    
     
     
     
391. DOLL A, Kapoor NS
     ASO Author Reflections: First Descriptions of Patients with Pregnancy Associated Breast Cancer and Subsequent Pregnancy.
     Ann Surg Oncol. 2024 Jul 23. doi: 10.1245/s10434-024-15854.
     PubMed    
     
     
     
392. STRIJBOS BTM, Janssen L, Voogd AC, Zwaans WAR, et al
     ASO Author Reflections: Persistent Pain After Breast Cancer Treatment, an Underreported Burden for Breast Cancer Survivors.
     Ann Surg Oncol. 2024 Jul 21. doi: 10.1245/s10434-024-15855.
     PubMed    
     
     
     
393. LIMBERG JN, Thomas SM, Dalton JC, Ntowe KW, et al
     Trajectory of Subsequent Breast Cancer Diagnoses in a Diverse Patient Cohort with Breast Atypia.
     Ann Surg Oncol. 2024 Jul 21. doi: 10.1245/s10434-024-15788.
     PubMed     Abstract available
     
     
     
394. GLENCER AC, Wanis KN, Brown S, Lucci A, et al
     Self-Reported Management of Inflammatory Breast Cancer Among the American Society of Breast Surgeons Membership: Consensus and Opportunities.
     Ann Surg Oncol. 2024 Jul 21. doi: 10.1245/s10434-024-15713.
     PubMed     Abstract available
     
     
     
395. PRATT CG, Whitrock JN, Carter MM, Long SA, et al
     Implementation of Choosing Wisely((R)) Recommendations for Lymph Node Surgery in Male Breast Cancer.
     Ann Surg Oncol. 2024 Jul 20. doi: 10.1245/s10434-024-15811.
     PubMed     Abstract available
     
     
     
396. STRIJBOS BTM, Janssen L, Voogd AC, Zwaans WAR, et al
     ASO Visual Abstract: Persistent Pain After Breast Cancer Treatment, an Underreported Burden for Breast Cancer Survivors.
     Ann Surg Oncol. 2024 Jul 18. doi: 10.1245/s10434-024-15850.
     PubMed    
     
     
     
397. GLENCER AC, Hunt KK, Teshome M
     ASO Author Reflections: Management of Inflammatory Breast Cancer: No Role for Surgical De-escalation Yet.
     Ann Surg Oncol. 2024 Jul 17. doi: 10.1245/s10434-024-15806.
     PubMed    
     
     
     
398. LIMBERG JN, Hwang ES
     ASO Author Reflections: Trajectory of Subsequent Breast Cancer After Breast Atypia Diagnosis Suggests Need for Vigilant Follow-up.
     Ann Surg Oncol. 2024 Jul 17. doi: 10.1245/s10434-024-15869.
     PubMed    
     
     
     
399. KRECKO LK, Neuman HB, Greenberg CC, Wilke LG, et al
     ASO Visual Abstract: Validation of the AJCC Eighth-Edition Breast Cancer Prognostic Staging System in Legacy Alliance Trials (AFT-01).
     Ann Surg Oncol. 2024 Jul 16. doi: 10.1245/s10434-024-15620.
     PubMed    
     
     
     
400. DALTON JC, Crowell KA, Ntowe KW, van den Bruele AB, et al
     Utility of Axillary Staging in Older Patients with HER2-Positive Breast Cancer.
     Ann Surg Oncol. 2024 Jul 16. doi: 10.1245/s10434-024-15812.
     PubMed     Abstract available
     
     
     
401. BELLINI A, Keegan THM, Li Q, Maguire FB, et al
     Disparities in the Occurrence of Long-Term Effects of Bone Marrow Suppression after Treatment in Adolescent Young Adult Breast Cancer Survivors.
     Ann Surg Oncol. 2024 Jul 16. doi: 10.1245/s10434-024-15707.
     PubMed     Abstract available
     
     
     
402. MUNCK F, Jensen MB, Vejborg I, Gerlach MK, et al
     ASO Visual Abstract: Residual Axillary Metastases in Node-Positive Breast Cancer Patients After Neoadjuvant Treatment-A Register-Based Study.
     Ann Surg Oncol. 2024 Jul 16. doi: 10.1245/s10434-024-15752.
     PubMed    
     
     
     
403. IWAI Y, Perez-Rojas S, Thomas SM, Tadros AB, et al
     ASO Visual Abstract: Guideline-Concordant Surgical Care for Lobular Versus Ductal Inflammatory Breast Cancer.
     Ann Surg Oncol. 2024 Jul 15. doi: 10.1245/s10434-024-15691.
     PubMed    
     
     
     
404. BHIMANI F, Feldman S, Cavalli A, Chen Y, et al
     ASO Visual Abstract: Axillary Reverse Mapping Aids in Reducing the Rates of Breast Cancer-Related Lymphedema in Underserved Ethnically Diverse Population.
     Ann Surg Oncol. 2024 Jul 15. doi: 10.1245/s10434-024-15832.
     PubMed    
     
     
     
405. TORTORELLO GN, Shafique N, Keele L, Susman CG, et al
     Longitudinal Increases in Time to Surgery for Patients with Breast Cancer: A National Cohort Study.
     Ann Surg Oncol. 2024 Jul 13. doi: 10.1245/s10434-024-15723.
     PubMed     Abstract available
     
     
     
406. PARK KU, Showalter SL, Dirbas FM
     Surgical Perspectives on the Updated ASTRO Guideline on Partial Breast Irradiation for Breast Cancer.
     Ann Surg Oncol. 2024 Jul 13. doi: 10.1245/s10434-024-15639.
     PubMed     Abstract available
     
     
     
407. SWITALLA KM, Boughey JC, Dimitroff K, Yau C, et al
     Clipping the Positive Lymph Node in Patients with Clinically Node Positive Breast Cancer Treated with Neoadjuvant Chemotherapy: Impact on Axillary Surgery in the ISPY-2 Clinical Trial.
     Ann Surg Oncol. 2024 Jul 12. doi: 10.1245/s10434-024-15792.
     PubMed     Abstract available
     
     
     
408. BELLINI A, Sauder CAM
     ASO Author Reflections: Disparities Exist for Adolescent Young Adult Breast Cancer Survivors.
     Ann Surg Oncol. 2024 Jul 11. doi: 10.1245/s10434-024-15803.
     PubMed    
     
     
     
409. CARROLL JF, Hoskin TL, Hieken TJ
     Correlation of PET-CT Nodal Imaging and Pathologic Response to Neoadjuvant Immunotherapy for Node-Positive Breast Cancer.
     Ann Surg Oncol. 2024 Jul 10. doi: 10.1245/s10434-024-15826.
     PubMed    
     
     
     
410. DOLL A, Lipsyc-Sharf M, Sim MS, Baker JL, et al
     Outcome of Patients with Pregnancy-Associated Breast Cancer Who Have Subsequent Pregnancies.
     Ann Surg Oncol. 2024 Jul 10. doi: 10.1245/s10434-024-15798.
     PubMed     Abstract available
     
     
     
411. NTOWE KW, Thomas SM, Dalton JC, Olunuga E, et al
     Demographics and Clinical Decision Making in Patients with Germline Moderate Penetrance Non-BRCA Mutations in Breast Cancer Related Genes.
     Ann Surg Oncol. 2024 Jul 8. doi: 10.1245/s10434-024-15793.
     PubMed     Abstract available
     
     
     
412. BOTTY VAN DEN BRUELE A, Weiss A
     Updated Guidelines on When to Consider Germline Testing for Patients with Breast Cancer.
     Ann Surg Oncol. 2024 Jul 5. doi: 10.1245/s10434-024-15638.
     PubMed    
     
     
     
413. CHEUN JH, Chung S, Han JH, Lee YW, et al
     Surveillance for Distant Metastasis in Breast Cancer Patients Who Underwent Contemporary Management: A Report from the Korean Breast Cancer Society Survivor Research Group.
     Ann Surg Oncol. 2024 Jul 5. doi: 10.1245/s10434-024-15665.
     PubMed     Abstract available
     
     
     
414. DI LENA E, Iny E, Wong SM, Bassel M, et al
     Impact of Margin Status on Local Recurrence in Patients with Breast Cancer Undergoing Breast-Conserving Surgery After Neoadjuvant Chemotherapy: A Retrospective Multi-Institutional Cohort Study.
     Ann Surg Oncol. 2024 Jul 5. doi: 10.1245/s10434-024-15716.
     PubMed     Abstract available
     
     
     
415. SHAH C, Boyages J, Koelmeyer L, Chen SL, et al
     Timing of Breast Cancer Related Lymphedema Development Over 3 Years: Observations from a Large, Prospective Randomized Screening Trial Comparing Bioimpedance Spectroscopy (BIS) Versus Tape Measure.
     Ann Surg Oncol. 2024 Jul 4. doi: 10.1245/s10434-024-15706.
     PubMed     Abstract available
     
     
     
416. BHIMANI F, Feldman S, McEvoy M
     ASO Author Reflections: Evaluating the Effectiveness of Axillary Reverse Mapping in Reducing Breast Cancer-Related Lymphedema Among Ethnically Diverse Patients.
     Ann Surg Oncol. 2024 Jul 4. doi: 10.1245/s10434-024-15663.
     PubMed    
     
     
     
417. BEAULIEU-JONES BR, Ha EJ, Fefferman A, Wang J, et al
     ASO Visual Abstract: Association of Race, Ethnicity, Language and Insurance and Time to Treatment Initiation Among Women with Breast Cancer at an Urban, Academic, Safety-Net Hospital.
     Ann Surg Oncol. 2024 Jul 3. doi: 10.1245/s10434-024-15647.
     PubMed    
     
     
     
418. HUA T, Mendoza S, McCririe-Balcom M, Kelley J, et al
     Routine Clinical Breast Examination Is a Low-Yield Practice Among Women at High Risk of Breast Cancer.
     Ann Surg Oncol. 2024 Jul 3. doi: 10.1245/s10434-024-15702.
     PubMed     Abstract available
     
     
     
419. MCINTOSH SA, Mactier M, Fairhurst K, Gath J, et al
     ASO Visual Abstract: Understanding Patient Experiences to Inform Future Studies to Optimize Personalization of Treatment for Early Breast Cancer.
     Ann Surg Oncol. 2024 Jul 3. doi: 10.1245/s10434-024-15683.
     PubMed    
     
     
     
420. MISHRA A, Deo SVS, Kumar N, Bansal B, et al
     ASO Visual Abstract: A Prospective Questionnaire-Based Study Evaluating Genetic Literacy and Impact of Brief Educational Intervention Among Breast Cancer Patients in a Low-Middle Income Country.
     Ann Surg Oncol. 2024 Jul 3. doi: 10.1245/s10434-024-15696.
     PubMed    
     
     
     
421. SHEN A, Qiang W, Zhao H, Han G, et al
     Contemporaneous Symptom Networks of Breast Cancer-Related Upper Limb Lymphedema: A Network Analysis.
     Ann Surg Oncol. 2024 Jul 3. doi: 10.1245/s10434-024-15676.
     PubMed     Abstract available
     
     
     
422. KING TA, Mittendorf EA
     Breast Articles From 2023: Informing Practice Across the Continuum of Care.
     Ann Surg Oncol. 2024;31:4470-4476.
     PubMed     Abstract available
     
     
     
423. SETO Y, Ishitobi M, Nakayama T
     ASO Author Reflections: Do Patients with Ipsilateral Breast Tumor Recurrence Prefer Repeat Breast-Conserving Surgery or Mastectomy?
     Ann Surg Oncol. 2024;31:4540.
     PubMed    
     
     
     
424. SETO Y, Ishitobi M, Shien T, Oshiro C, et al
     Patient Preference for Surgical Methods for Ipsilateral Breast Tumor Recurrence.
     Ann Surg Oncol. 2024;31:4512-4517.
     PubMed     Abstract available
     
     
     
425. KIM M, Gilliland JL, Parnes MF, Bruce C, et al
     BREAST-Q REACT: Qualitative Assessment of the Design, Functionality, and Clinical Utility of a New Score Interpretation Tool.
     Ann Surg Oncol. 2024;31:4498-4511.
     PubMed     Abstract available
     
     
     
426. CHU JJ, Tadros AB, Vingan PS, Assel MJ, et al
     ASO Visual Abstract: Remote Symptom Monitoring with Clinical Alerts Following Mastectomy: Do Early Symptoms Predict 30-Day Surgical Complications.
     Ann Surg Oncol. 2024;31:4547-4548.
     PubMed    
     
     
     June 2024
427. JONNALAGADDA P, Rahurkar S
     ASO Author Reflections: Disparities in Triple-Negative Breast Cancer Care: Are Some Patients Being Overlooked?
     Ann Surg Oncol. 2024 Jun 29. doi: 10.1245/s10434-024-15640.
     PubMed    
     
     
     
428. PILEWSKIE M, Eroglu I, Sevilimedu V, Le T, et al
     Participation in a High-Risk Program Is Associated with a Diagnosis of Earlier-Stage Disease Among Women at Increased Risk for Breast Cancer Development.
     Ann Surg Oncol. 2024 Jun 29. doi: 10.1245/s10434-024-15633.
     PubMed     Abstract available
     
     
     
429. STRIJBOS BTM, Janssen L, Voogd AC, Zwaans WAR, et al
     Persistent Pain After Breast Cancer Treatment, an Underreported Burden for Breast Cancer Survivors.
     Ann Surg Oncol. 2024 Jun 28. doi: 10.1245/s10434-024-15682.
     PubMed     Abstract available
     
     
     
430. CORTINA CS, Purdy A, Brazauskas R, Stachowiak SM, et al
     The Impact of a Breast Cancer Risk Assessment on the Decision for Gender-Affirming Chest Masculinization Surgery in Transgender and Gender-Diverse Individuals: A Pilot Single-Arm Educational Intervention Trial.
     Ann Surg Oncol. 2024 Jun 28. doi: 10.1245/s10434-024-15701.
     PubMed     Abstract available
     
     
     
431. LEE EG, Lee DE, Jung SY, Han JH, et al
     ASO Author Reflections: Assessing the Efficacy of Multimodal Sentinel Lymph Node Mapping in Breast Cancer Patients After Neoadjuvant Chemotherapy.
     Ann Surg Oncol. 2024 Jun 24. doi: 10.1245/s10434-024-15580.
     PubMed    
     
     
     
432. JUNG JJ, Moon HG
     ASO Author Reflections: Contralateral Axillary Metastasis in Breast Cancer: Prognostic Variability and Benefits of Surgical Treatment.
     Ann Surg Oncol. 2024 Jun 20. doi: 10.1245/s10434-024-15440.
     PubMed    
     
     
     
433. IWAI Y, Perez-Rojas S, Thomas SM, Tadros AB, et al
     Guideline-Concordant Surgical Care for Lobular Versus Ductal Inflammatory Breast Cancer.
     Ann Surg Oncol. 2024 Jun 17. doi: 10.1245/s10434-024-15540.
     PubMed     Abstract available
     
     
     
434. CARROLL JF, Hoskin TL, Leon-Ferre RA, Boughey JC, et al
     Impact of Presenting Stage on Overall Survival in Patients Treated with Neoadjuvant Chemotherapy for Triple Negative Breast Cancer.
     Ann Surg Oncol. 2024 Jun 13. doi: 10.1245/s10434-024-15583.
     PubMed     Abstract available
     
     
     
435. LEE EG, Lee DE, Jung SY, Han JH, et al
     ASO Visual Abstract: Clinical Application of Multimodal Sentinel Lymph Node Mapping Method in Patients with Breast Cancer Undergoing Neoadjuvant Chemotherapy: An Interim Analysis.
     Ann Surg Oncol. 2024 Jun 12. doi: 10.1245/s10434-024-15482.
     PubMed    
     
     
     
436. MISHRA A, Deo SVS, Kumar N, Bansal B, et al
     A Prospective Questionnaire-Based Study Evaluating Genetic Literacy and Impact of Brief Educational Intervention Among Breast Cancer Patients in a Low- to Middle-Income Country.
     Ann Surg Oncol. 2024 Jun 11. doi: 10.1245/s10434-024-15527.
     PubMed     Abstract available
     
     
     
437. BHIMANI F, Feldman S, Cavalli A, Chen Y, et al
     Axillary Reverse Mapping Aids in Reducing the Rates of Breast Cancer-Related Lymphedema in Underserved Ethnically Diverse Population.
     Ann Surg Oncol. 2024 Jun 6. doi: 10.1245/s10434-024-15577.
     PubMed     Abstract available
     
     
     
438. JUNG JJ, Cheun JH, Kang E, Shin I, et al
     ASO Visual Abstract: Survival After the Contralateral Axillary Metastasis in Breast Cancer.
     Ann Surg Oncol. 2024 Jun 6. doi: 10.1245/s10434-024-15546.
     PubMed    
     
     
     
439. GILMORE RC, Fine RE
     Reply to: Comment on: Cryoablation Without Excision for Low-Risk Early-Stage Breast Cancer: 3-Year Interim Analysis of Ipsilateral Breast Tumor Recurrence in the ICE3 Trial.
     Ann Surg Oncol. 2024 Jun 5. doi: 10.1245/s10434-024-15502.
     PubMed    
     
     
     
440. MYERS SP, Sevilimedu V, Jones VM, Abuhadra N, et al
     ASO Visual Abstract: Impact of Neoadjuvant Chemoimmunotherapy on Surgical Outcomes and Time to Radiation in Triple-Negative Breast Cancer.
     Ann Surg Oncol. 2024 Jun 4. doi: 10.1245/s10434-024-15491.
     PubMed    
     
     
     
441. KRECKO LK, Neuman HB, Greenberg CC, Wilke LG, et al
     Validation of the AJCC 8th Edition Breast Cancer Prognostic Staging System in Legacy Alliance Trials (AFT-01).
     Ann Surg Oncol. 2024 Jun 2. doi: 10.1245/s10434-024-15477.
     PubMed     Abstract available
     
     
     
442. CHAUHAN H, Ashrafian H, Takats Z, Leff DR, et al
     ASO Author Reflections: The Impact of DCIS on Positive Margin Rates.
     Ann Surg Oncol. 2024;31:3948-3949.
     PubMed    
     
     
     
443. CHAUHAN H, Jiwa N, Nagarajan VR, Thiruchelvam P, et al
     Clinicopathological Predictors of Positive Resection Margins in Breast-Conserving Surgery.
     Ann Surg Oncol. 2024;31:3939-3947.
     PubMed     Abstract available
     
     
     
444. CARROLL MC, Yen RW, Leech M, Barth RJ Jr, et al
     A Systematic Review and Meta-analysis of the Role of Preoperative MRI in In-breast Tumor Recurrence After Breast-Conserving Surgery.
     Ann Surg Oncol. 2024;31:3926-3938.
     PubMed     Abstract available
     
     
     
445. VINGAN PS, Serafin J, Boe L, Zhang KK, et al
     Reducing Disparities: Regional Anesthesia Blocks for Mastectomy with Reconstruction Within Standardized Regional Anesthesia Pathways.
     Ann Surg Oncol. 2024;31:3684-3693.
     PubMed     Abstract available
     
     
     
446. GONZALEZ L, Johnson NC, Jones VC, Taylor L, et al
     An Observational Cohort Study Comparing Positive Margin Rates Using an Electromagnetic Navigational System Versus Wire Localization in Breast Conservation Surgery.
     Ann Surg Oncol. 2024;31:3669-3671.
     PubMed    
     
     
     
447. KIM Y, Ganduglia-Cazaban C, Tamirisa N, Lucci A, et al
     Contemporary Analysis of Reexcision and Conversion to Mastectomy Rates and Associated Healthcare Costs for Women Undergoing Breast-Conserving Surgery.
     Ann Surg Oncol. 2024;31:3649-3660.
     PubMed     Abstract available
     
     
     
448. 
     The American Society of Breast Surgeons Official Proceedings, Volume XXV 2024 Annual Meeting Scientific Session Abstracts.
     Ann Surg Oncol. 2024;31.
     PubMed    
     
     
     May 2024
449. SIEGEL JB, Bertolino M, Mukherjee R, Meeder K, et al
     Racial Disparities in Breast Cancer Genetic Testing May be Mitigated by Counseling.
     Ann Surg Oncol. 2024 May 29. doi: 10.1245/s10434-024-15434.
     PubMed     Abstract available
     
     
     
450. SIEGEL JB, Bertolino M, Mukherjee R, Meeder K, et al
     ASO Visual Abstract: Racial Disparities in Breast Cancer Genetic Testing may be Mitigated by Counseling.
     Ann Surg Oncol. 2024 May 29. doi: 10.1245/s10434-024-15536.
     PubMed    
     
     
     
451. NG TP, Loo BYK, Yong N, Chia CLK, et al
     ASO Visual Abstract: Implant-Based Breast Reconstruction After Mastectomy for Breast Cancer: A Meta-analysis of Randomised Controlled Trials and Prospective Studies Comparing Use of Acellular Dermal Matrix (ADM) Versus Without ADM.
     Ann Surg Oncol. 2024 May 23. doi: 10.1245/s10434-024-15446.
     PubMed    
     
     
     
452. MYERS SP, Downs-Canner SM
     ASO Author Reflections: Immune-Related Adverse Events During Neoadjuvant Chemoimmunotherapy for Triple-Negative Breast Cancer May Influence Time to Adjuvant Radiation.
     Ann Surg Oncol. 2024 May 22. doi: 10.1245/s10434-024-15445.
     PubMed    
     
     
     
453. MCINTOSH SA, Mactier M, Fairhurst K, Gath J, et al
     Understanding Patient Experiences to Inform Future Studies to Optimize Personalization of Treatment for Early Breast Cancer.
     Ann Surg Oncol. 2024 May 21. doi: 10.1245/s10434-024-15459.
     PubMed     Abstract available
     
     
     
454. ROACH EA, Weil CR, Cannon G, Grant J, et al
     ASO Visual Abstract: The Role of Axillary Lymph Node Dissection Versus Sentinel Lymph Node Dissection in Breast Cancer Patients with Clinical N2b-N3c Disease Who Receive Adjuvant Radiotherapy.
     Ann Surg Oncol. 2024 May 20. doi: 10.1245/s10434-024-15419.
     PubMed    
     
     
     
455. MYERS SP, Sevilimedu V, Jones VM, Abuhadra N, et al
     Impact of Neoadjuvant Chemoimmunotherapy on Surgical Outcomes and Time to Radiation in Triple-Negative Breast Cancer.
     Ann Surg Oncol. 2024 May 20. doi: 10.1245/s10434-024-15359.
     PubMed     Abstract available
     
     
     
456. PARVEZ E, Bogach J, Kirkwood D, Pond G, et al
     ASO Visual Abstract: Immigration Status and Breast Cancer Surgery Quality of Care Metrics: A Population-Level Analysis.
     Ann Surg Oncol. 2024 May 11. doi: 10.1245/s10434-024-15376.
     PubMed    
     
     
     
457. NGUYEN CL, Cui R, Zhou M, Ali F, et al
     ASO Visual Abstract: Cost-Effectiveness of Radar Localization Versus Wire Localization for Wide Local Excision of Non-palpable Breast Cancer.
     Ann Surg Oncol. 2024 May 9. doi: 10.1245/s10434-024-15383.
     PubMed    
     
     
     
458. LEE EG, Lee DE, Jung SY, Han JH, et al
     Clinical Application of Multimodal Sentinel Lymph Node Mapping Method in Patients with Breast Cancer Undergoing Neoadjuvant Chemotherapy: An Interim Analysis.
     Ann Surg Oncol. 2024 May 8. doi: 10.1245/s10434-024-15317.
     PubMed     Abstract available
     
     
     
459. HAMID SA, Schultz KS, Greenup RA
     ASO Author Reflections: "Peace of Mind" After Surgery for Breast Cancer: Implications for Preference-Sensitive Shared Decision Making.
     Ann Surg Oncol. 2024 May 7. doi: 10.1245/s10434-024-15408.
     PubMed    
     
     
     
460. PFOB A, Kokh DB, Surovtsova I, Riedel F, et al
     Oncologic Outcomes for Different Axillary Staging Techniques in Patients with Nodal-Positive Breast Cancer Undergoing Neoadjuvant Systematic Treatment: A Cancer Registry Study.
     Ann Surg Oncol. 2024 May 6. doi: 10.1245/s10434-024-15292.
     PubMed     Abstract available
     
     
     
461. NIJVELDT JJ, Rajan KK, Boersma K, Noorda EM, et al
     ASO Visual Abstract: Implementation of the Targeted Axillary Dissection Procedure in Clinically Node-Positive Breast Cancer-A Retrospective Analysis.
     Ann Surg Oncol. 2024 May 6. doi: 10.1245/s10434-024-15375.
     PubMed    
     
     
     
462. MUNCK F, Jensen MB, Vejborg I, Gerlach MK, et al
     Residual Axillary Metastases in Node-Positive Breast Cancer Patients After Neoadjuvant Treatment: A Register-Based Study.
     Ann Surg Oncol. 2024 May 4. doi: 10.1245/s10434-024-15354.
     PubMed     Abstract available
     
     
     
463. JUNG JJ, Cheun JH, Kang E, Shin I, et al
     Survival After Contralateral Axillary Metastasis in Breast Cancer.
     Ann Surg Oncol. 2024 May 2. doi: 10.1245/s10434-024-15370.
     PubMed     Abstract available
     
     
     
464. GREENE AJE, Davis J, Moon J, Dubin I, et al
     Determination of Factors Associated with Upstage in Atypical Ductal Hyperplasia to Identify Low-Risk Patients Where Active Surveillance May be an Alternative.
     Ann Surg Oncol. 2024;31:3177-3185.
     PubMed     Abstract available
     
     
     
465. CHU JJ, Tadros AB, Vingan PS, Assel MJ, et al
     Remote Symptom Monitoring with Clinical Alerts Following Mastectomy: Do Early Symptoms Predict 30-Day Surgical Complications.
     Ann Surg Oncol. 2024;31:3377-3386.
     PubMed     Abstract available
     
     
     April 2024
466. KAUFMAN C, Sarantou T, Donovan C, Kamali Polat A, et al
     ASO Author Reflections: Increasing Time of Diagnosis to Breast Cancer Surgery.
     Ann Surg Oncol. 2024 Apr 29. doi: 10.1245/s10434-024-15295.
     PubMed    
     
     
     
467. ROACH EA, Weil CR, Cannon G, Grant J, et al
     The Role of Axillary Lymph Node Dissection versus Sentinel Lymph Node Dissection in Breast Cancer Patients with Clinical N2b-N3c Disease Who Receive Adjuvant Radiotherapy.
     Ann Surg Oncol. 2024 Apr 22. doi: 10.1245/s10434-024-15280.
     PubMed     Abstract available
     
     
     
468. PARVEZ E, Bogach J, Kirkwood D, Pond G, et al
     Immigration Status and Breast Cancer Surgery Quality of Care Metrics: A Population-Level Analysis.
     Ann Surg Oncol. 2024 Apr 18. doi: 10.1245/s10434-024-15250.
     PubMed     Abstract available
     
     
     
469. XIONG M, Young AT, Fernandez A, Jones JS, et al
     Understanding Breast Cancer Surgery Through Tiktok: an Analysis of Video Content and Viewer Engagement.
     Ann Surg Oncol. 2024 Apr 9. doi: 10.1245/s10434-024-15268.
     PubMed     Abstract available
     
     
     
470. QIU M, Liang F, Xie Y, Yang H, et al
     Clinical Outcomes of Transaxillary Reverse-Sequence Endoscopic Nipple-Sparing Mastectomy and Direct-to-Implant Prepectoral Breast Reconstruction: A Prospective Study of Initial 68 Procedures.
     Ann Surg Oncol. 2024;31:2777-2785.
     PubMed     Abstract available
     
     
     
471. WESTENEND P, Meurs C, van Bekkum S, van Rosmalen J, et al
     ASO Author Reflections: What Can Prediction Models for Upstaging of DCIS Diagnosed on Biopsy Tell Us About DCIS Surveillance Trials?
     Ann Surg Oncol. 2024;31:2272-2273.
     PubMed    
     
     
     
472. EVERIDGE SA, Sun J, Teshome M, Tamirisa N, et al
     ASO Visual Abstract: Lobular Neoplasia Diagnosed by MRI-Guided Breast Biopsy-Identifying Upgrade Rate to Malignancy and Outcomes of Clinical and Surgical Management.
     Ann Surg Oncol. 2024;31:2276-2277.
     PubMed    
     
     
     
473. SINGH P, Agnese D, Amin M, Barrio AV, et al
     Society of Surgical Oncology Breast Disease Site Working Group Statement on Contralateral Mastectomy: Indications, Outcomes, and Risks.
     Ann Surg Oncol. 2024;31:2212-2223.
     PubMed     Abstract available
     
     
     
474. RUBENSTEIN RN, Kim M, Plotsker EL, Chu JJ, et al
     Early Complications in Prepectoral Tissue Expander-Based Breast Reconstruction.
     Ann Surg Oncol. 2024;31:2766-2776.
     PubMed     Abstract available
     
     
     
475. QIU M, Liang F, Xie Y, Yang H, et al
     ASO Author Reflections: A Novel Technique of Transaxillary Reverse-Sequence Endoscopic Nipple-Sparing Mastectomy and Direct-to-Implant Prepectoral Breast Reconstruction.
     Ann Surg Oncol. 2024;31:2791-2792.
     PubMed    
     
     
     
476. POLIDORIO N, Montagna G, Sevilimedu V, Le T, et al
     Do HER2-Low Tumors Have a Distinct Clinicopathologic Phenotype?
     Ann Surg Oncol. 2024;31:2231-2243.
     PubMed     Abstract available
     
     
     
477. QIU M, Liang F, Xie Y, Yang H, et al
     ASO Visual Abstract: Clinical Outcomes of Transaxillary Reverse-Sequence Endoscopic Nipple-Sparing Mastectomy and Direct-to-Implant Prepectoral Breast Reconstruction-A Prospective Study of Initial 68 Procedures.
     Ann Surg Oncol. 2024;31:2794-2795.
     PubMed    
     
     
     
478. EVERIDGE SA, Sun J, Teshome M, Tamirisa N, et al
     Lobular Neoplasia Diagnosed by MRI-Guided Breast Biopsy: Identifying Upgrade Rate to Malignancy and Outcomes of Clinical and Surgical Management.
     Ann Surg Oncol. 2024;31:2224-2230.
     PubMed     Abstract available
     
     
     
479. WIENER AA, Schumacher JR, Perlman SB, Wilke LG, et al
     A Four-Arm Randomized Clinical Trial of Topical Pain Control for Sentinel Node Radiotracer Injections in Patients with Breast Cancer.
     Ann Surg Oncol. 2024 Apr 1. doi: 10.1245/s10434-024-15235.
     PubMed     Abstract available
     
     
     March 2024
480. SCODARI BT, Schaefer AP, Kapadia NS, Brooks GA, et al
     The Association Between Oncology Outreach and Timely Treatment for Rural Patients with Breast Cancer: A Claims-Based Approach.
     Ann Surg Oncol. 2024 Mar 27. doi: 10.1245/s10434-024-15195.
     PubMed     Abstract available
     
     
     
481. NIJVELDT JJ, Rajan KK, Boersma K, Noorda EM, et al
     Implementation of the Targeted Axillary Dissection Procedure in Clinically Node-Positive Breast Cancer: A Retrospective Analysis.
     Ann Surg Oncol. 2024 Mar 24. doi: 10.1245/s10434-024-15182.
     PubMed     Abstract available
     
     
     
482. NGUYEN CL, Cui R, Zhou M, Ali F, et al
     Cost-Effectiveness of Radar Localisation Versus Wire Localisation for Wide Local Excision of Non-palpable Breast Cancer.
     Ann Surg Oncol. 2024 Mar 12. doi: 10.1245/s10434-024-15142.
     PubMed     Abstract available
     
     
     
483. CHUNG AP, Dang CM, Karlan SR, Amersi FF, et al
     ASO Visual Abstract: A Prospective Study of Sentinel Node Biopsy Omission in Women Age >/= 65 with ER+ Breast Cancer.
     Ann Surg Oncol. 2024 Mar 6. doi: 10.1245/s10434-024-15137.
     PubMed    
     
     
     
484. COSTARELLI L, Arienzo F, Broglia L, La Pinta M, et al
     Clipping a Positive Lymph Node Improves Accuracy of Nodal Staging After Neoadjuvant Chemotherapy for Breast Cancer Patients, but Does It Drive Management Changes?
     Ann Surg Oncol. 2024 Mar 1. doi: 10.1245/s10434-024-15052.
     PubMed     Abstract available
     
     
     February 2024
485. JAKUB JW, Advani P, Maxwell R, Vallow L, et al
     SOUND (Sentinel Node Versus Observation After Axillary Ultrasound) Trial: Are We Ready to Change the Tune of Our Breast Cancer Practice?
     Ann Surg Oncol. 2024 Feb 28. doi: 10.1245/s10434-024-15111.
     PubMed    
     
     

Thank you for your interest in scientific medicine.

AMEDEO Breast Cancer is free of charge.